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EDITORIAL SUMMARY  A series of techniques (echocardiography, novel object recognition, grip 45 
strength, rotarod, glucose and insulin tolerance tests, body composition, and energy expenditure) 46 
are used to assess the health of mice.  47 
 48 
TWEET Assessing the health of aging mice 49 
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Abstract  64 
The number of people aged over 65 is expected to double in the next 30 years. For many, 65 
living longer will mean spending more years with the burdens of chronic diseases such as 66 
Alzheimer’s, cardiovascular disease, and diabetes. Although researchers have made rapid 67 
progress in developing geroprotective interventions that target mechanisms of ageing and 68 
delay or prevent the onset of multiple concurrent age-related diseases, a lack of 69 
standardized techniques to assess healthspan in preclinical murine studies has resulted in 70 
reduced reproducibility and slowed progress. To overcome this, major centres in Europe and 71 
the USA skilled in healthspan analysis came together to agree upon a toolbox of techniques 72 
which can be used to consistently assess the healthspan of mice. Here, we describe the 73 
agreed toolbox which contains protocols for echocardiography, novel object recognition, grip 74 
strength, rotarod, glucose and insulin tolerance tests, body composition, and energy 75 
expenditure. They can be performed longitudinally in the same mouse over a period of 4-6 76 
weeks to test how candidate geroprotectors affect cardiac, cognitive, neuromuscular and 77 



















  97 
Introduction 98 
As the average age of the world population increases, for many living longer will not 99 
mean living healthier. The number of healthy years is predicted to increase at a slower pace 100 
or not at all compared to lifespan. The result is that people are expected to spend an 101 
increasing number of years suffering from the burdens of multiple chronic age-associated 102 
diseases such as heart disease, Alzheimer’s disease, and diabetes. Over 60% of those aged 103 
65 and over have more than one chronic condition (multimorbidity), often leading to frailty 104 
(an accumulation of multiple deficits and loss of resilience to adverse events) and a resulting 105 
loss of independence1. This continuously growing trend will mean a substantial increase in 106 
health and social care costs1. For example the European Commission has estimated that 107 
every year of health lost will cost to the European Union 0.3 percentage point of GDP, 108 
equivalent to 54 billion euros1. 109 
For this reason, studies on how to maintain health with age and how to compress the 110 
period of multimorbidity have become an emerging priority2. Recent research suggests that 111 
ageing, the major risk factor for the development of many deleterious chronic conditions, 112 
may be modifiable by both lifestyle (e.g., diet, exercise) and pharmacological interventions 113 
(geroprotectors), which in turn may be able to simultaneously delay the onset of multiple 114 
age-related diseases and reduce the risk of developing multimorbidity and frailty1. This has 115 
stimulated great interest in developing interventions to promote healthspan3-6.  116 
Mice are the model organisms most often used for preclinical analysis of 117 
interventions due to their mammalian physiology, which resembles that of humans in many 118 
aspects, the relatively inexpensive cost to house and treat the animals, and their relatively 119 
short lifespan. However, measuring healthspan (the portion of life that is relatively healthy 120 
and free from major deficits that impair quality of life) is challenging because of the multiple 121 
parameters which need to be assessed. Despite this difficulty, it is widely agreed that 122 
measuring healthspan comprehensively is imperative1,7. Maximizing the robustness, 123 
reproducibility, and utility of these measurements of healthspan requires a consensus on 124 
which outcomes should be measured, the ages at which mice should be examined, and the 125 
frequency of examination.  126 
At present the majority of laboratories do not comprehensively assess healthspan, 127 
and testing is not all-inclusive in relation to organ systems but rather focused on one or two 128 
specific organs of choice. Further, there are differences in the experimental design and the 129 
way the techniques are performed. In combination, these result in both a knowledge gap 130 
about the effectiveness of candidate geroprotective agents, and a lack of reproducibility. 131 
Therefore, a consensus on the best practices to assess healthspan and development of a 132 
standard operating procedure (SOP) is required.   133 
Development of the toolbox  134 
 In an attempt to overcome these limitations, experts in healthspan assessment of 135 
mice gathered to compare practices in their laboratories.  The toolbox was developed via a 136 
series of meetings and conference phone calls, culminating in in-person meeting at a 137 
MouseAGE/INFRARONTIER-sponsored workshop in Athens, Greece in October of 2017. 138 
Here, we present the consensus toolbox for the measurement of healthspan in ageing mice 139 
using a battery of tests, which assess the major organ systems in the same animals 140 
longitudinally. The toolbox consists of protocols assessing cardiac function 141 
(echocardiography), muscle strength and neuromuscular function (grip strength, hanging 142 
bar, and rotarod), metabolic health (glucose and insulin tolerance test, body composition, 143 
and energy balance), and cognitive function (novel object recognition).  We also recommend 144 
mice are assessed for frailty. The protocols in this toolbox can be repeated longitudinally 145 
during the lifespan of a mouse, or during the course of treatment of aged mice to which 146 
geroprotective agents have been administered. At the time of euthanasia, collection of 147 
tissues for histological analysis is also recommended for studies with a planned euthanasia 148 
age.  149 
The assays were chosen based on the evaluation of a number of criteria: clinical 150 
relevance, good reproducibility, a low level of invasiveness or exposure to radiation and 151 
stress for the animal (e.g. no need for anaesthesia when possible), and a low level of 152 
technical difficulty.  153 
 154 
For the evaluation of cardiac function, echocardiography was selected over blood 155 
pressure measurement despite the need for anaesthesia and for specialized personnel to 156 
perform the analysis because the latter procedure has very high variability, likely due to 157 
stress, and there is significant difficulty in reproducing results.  158 
 159 
In the case of neuromuscular function, we chose a panel of easy to perform tests 160 
with very low impact on animal welfare. Among these assays, grip strength, cage top and 161 
hanging wire  were chosen over the testing of forced treadmill running capacity (FTR). Wire 162 
hang is also known as wire suspension latency test, wire hang, hang test or body 163 
suspension in the literature. This combination of tests was chosen because they are less 164 
demanding for the aged animals than the treadmill running test. Aged animals may be lost 165 
during the latter and therefore it is preferable to perform it on a dedicated cohort of animals. 166 
We have also chosen rotarod because, in addition to serving as another measure of 167 
endurance, it also assesses coordination and balance.  Alternative assays such as beam 168 
balance and beam walking assay are less effective at detecting mild impairments than 169 
rotarod 8. When performing grip strength it is worth remembering that it has the significant 170 
limitation of being very sensitive to the ability of the operator. In addition, several of these 171 
assays are heavily influenced by the weight of the animal. For this reason, the evaluation of 172 
the neuromuscular system relies on more than one test, and where possible, it is advisable 173 
to verify conclusions by post-mortem histological analysis of muscle. We also suggest to 174 
perform follow-up studies if there is any evidence of a change in muscle function, using FTR 175 
and evoked leg muscle strength and fatigue 3,5,9,10.  176 
 177 
For metabolic function, glucose and insulin tolerance tests were selected to measure 178 
glucose homeostasis over the hyperinsulinemic-euglycemic clamp due to the requirement for 179 
surgery and euthanasia following the clamp procedure. This precludes longitudinal 180 
assessment and is very stressful to the animals. We selected intraperitoneal (IP) dosing of 181 
glucose due to the ease of training individuals and the consideration that oral glucose 182 
delivery is considered more stressful. Body composition analysis by MRI was selected over 183 
DXA due to the requirement for anaesthesia,  the speed of measurement, and accuracy, as 184 
MRI provides a better estimate of both fat mass and lean tissue mass 11. Metabolic 185 
chambers to assess energy balance via indirect calorimetry, activity tracking, and food intake 186 
measurement are the gold standard method to track energy balance and can be used 187 
longitudinally with a minimum of stress to the animals. They were selected over alternative 188 
apparatus that can only track a subset of these measurements, and thus provide only a 189 
partial snapshot of energy balance.  190 
 191 
A separate session was dedicated to the choice of behavioural tests. Consensus 192 
versions of protocols for each technique were modified from those already published by the 193 
individual authors3-6,12-21. A key requirement for cognitive assays suitable for longitudinal 194 
analyses is that order effects need to be avoided as much as possible. A number of 195 
commonly used cognitive tasks in rodents, such as the Morris water maze or contextual fear 196 
conditioning, have limited value for longitudinal assessments because performance on these 197 
assays will be strongly influenced by previous experiences in these tasks. We chose novel 198 
object recognition as it is well suited for multiple longitudinal assessments of the same sets 199 
of mice using different object pairs. Other behavioural assays, such as the recently 200 
developed touchscreen-based automated battery system 22, would also be suitable for 201 
longitudinal assessments of cognitive function. However, novel object recognition has 202 
particularly low demands regarding the availability of specialized equipment and can hence 203 
be readily implemented in a broad range of laboratories. Moreover, novel object recognition 204 
places minimal stress on the animals tested as it does not involve exposure to aversive 205 
stimuli, food restriction, single housing or extensive periods of pre-training. More detailed 206 
explanations of novel object recognition can be found in Benice and Raber (2008)23.  207 
 208 
We also recommend uses  assess mice according to the frailty index, based on the 209 
Rockwood frailty score including 31 different parameters, which we do not describe here due 210 
to the extremely detailed description available from the developers 24-26. This is our preferred 211 
method to score frailty compared to  measuring frailty using a Fried Frailty Criteria-like score 212 
because the latter is based on the assessment of only 4 criteria (grip-strength, walking 213 
speed, physical activity, and endurance) and was considered more a measure of 214 
musculoskeletal fitness rather than an accumulation of deficits in several organ systems. 215 
The Rockwood-like frailty index better captures the potential benefits of geroprotectors 216 
across multiple systems.  217 
At the end of the experiments we recommend harvesting as many tissues as 218 
possible, as well as blood for clinical biochemistry and to perform analysis of bone, e.g. by 219 
X-Ray microCT. It was decided that analysis of bone would be done only after terminal 220 
anaesthesia to avoid potential detrimental effects due to radiation exposure. Longitudinal 221 
analysis of bone requires exposure of mice to repetitive doses of radiation and anaesthesia. 222 
Although the dose received at each imaging session is small and only in the region of 223 
interest, the cumulative effects are unknown.  224 
An alternative approach to the testing of healthspan was proposed by Sukoff-Rizzo et 225 
al. 27 However, this approach was primarily focused on the in-depth study of motor, sensory, 226 
and cognitive function, and does not evaluate important parameters of healthspan such as 227 
cardiac and metabolic function 27. Considering the longitudinal nature of these studies and 228 
considering that some of the tests reported by the protocol of Sukoff-Rizzo are taxing for 229 
ageing animals, we advise investigators to perform some of the tests described in this 230 
protocol in a second, parallel cohort of animals when alterations in neuromuscular function 231 
or behaviour are found using our pipeline.  232 
Using the procedures included in this toolbox, our laboratories have successfully 233 
characterized the effectiveness of several compounds, including metformin18, nicotinamide20, 234 
rapamycin4,6, and senolytics28,29, as well as other interventions including diet30-32 and 235 
exercise33 as geroprotective agents on mice, and determined the effect of specific genetic 236 
modifications 12,19,34 on the health and longevity of mice. Consensus across laboratories was 237 
reached by performing a comparison of the protocols in use in each laboratory, together with 238 
evidence of best practice and consideration of animal welfare, particularly when animals 239 
reach old age.  240 
 241 
Application of the toolbox 242 
Healthspan assessment can be used when studying gene function using genetically 243 
modified animals, or for testing new compounds (e.g. geroprotectors), diet or exercise 244 
regimens. For example, we have used this toolbox to identify new genes involved in the 245 
development of age-related diseases, which can be used as novel drug targets12. In addition, 246 
we have studied the efficacy, side effects, and mechanism of action of geroprotectors using 247 
several tests in this toolbox. These drugs have emerged for their ability to delay the onset of 248 
multiple concurrent age-related diseases and boost resilience by modulating mechanisms of 249 
ageing such as senescence, autophagy, and inflammation1. More than 200 compounds have 250 
been described as geroprotectors (http://geroprotectors.org/). Our studies, collectively, have 251 
shown that drugs such as rapamycin, resveratrol, metformin, senolytics (e.g. fisetin, 252 
dasatininb, and querectin35,36) which remove senescent cells, or dietary interventions can 253 
slow the development of cataracts, osteoarthritis, osteoporosis, the loss of muscle mass and 254 
can improve cardiac function3-6,13-21,35-42. Similarly, we have shown that decreased 255 
consumption of protein or of specific dietary amino acids improves metabolic health31,43. We 256 
recommend the use of this toolbox for a first assessment of healthspan whenever testing 257 
geroprotectors or assessing the function of specific genes in healthy ageing. These studies 258 
can serve as a guide for a subsequent, in-depth assessment of specific organ systems and 259 
healthspan effects.  260 
The toolbox has been designed with C57BL/6J mice in mind because of the amount 261 
of data already available for this commonly used strain. However, with some modification it 262 
can be used for other strains such as UM-HET3 mice (the F2 progeny of (BALB/cJ x 263 
C57BL/6J) mothers and (C3H/HeJ x DBA/2J) fathers; parental strains from The Jackson 264 
Laboratory). Some procedures have also been tested on mice of different genetic 265 
backgrounds, including PWK/PhJ (The Jackson Laboratory) and C57BL/6NHsd, 266 
DBA/2NHsd, 129P2/OlaHsd, and C3H/HeNHsd (Envigo), and many of the toolbox 267 
procedures have been tested on genetically modified mice, including dwarf and progeroid 268 
animals 15,34,44-46. 269 
 270 
Comparison with other approaches 271 
 To date, the vast majority of healthspan studies have taken an ad hoc approach to 272 
the collection of longitudinal data that has been limited by the interests of the investigators in 273 
one or two specific tissues. This has limited the amount of data collected in a single study, 274 
slowed scientific advance overall and limited the translation of geroscience discoveries. For 275 
example, it was only recently shown that short-term calorie restriction and rapamycin can 276 
rejuvenate the aging mouse heart, reversing pre-existing age-dependent cardiac 277 
hypertrophy and diastolic dysfunction47,48. If these types of studies were routinely performed 278 
during longevity studies, the beneficial effects of rapamycin on cardiac diastolic function 279 
would have been identified several years earlier. For example, while there have been 280 
several studies demonstrating that late-life treatment with rapamycin extends lifespan6,49-51, 281 
none of these studies examined cardiac function. Likewise, there are studies testing 282 
geroprotectors and focusing on cognition and metabolic health, showing beneficial effects on 283 
cognition in mouse models of Alzheimer’s disease or aged mice52,53, and improving the 284 
metabolic health of aged mice20,29,54. For the greater part, however, those studies that 285 
examined cognition did not assess metabolic health, and vice-versa. It would also be 286 
interesting to know if the beneficial effects of these short-term interventions persist or are 287 
temporary.   288 
The major problem of older age is that “it comes as a package”55 and the major 289 
health challenges are due to the accumulation of deficits and the presence of concurrent 290 
diseases. Therefore, a systematic and holistic approach which goes beyond the study of the 291 
single disease is required. In addition the use of a standardised toolbox allows the 292 
comparison of measure across laboratories, improving reproducibility. For example, the 293 
effects of interventions including intermittent fasting and rapamycin have alternatively been 294 
reported to either have minimal or significant effects on aging and healthspan 4,32,56,57; it is 295 
difficult to determine whether the differences are due to the differences in regimen or to the 296 
specific endpoints considered. While a few studies have provided a comprehensive 297 
assessment of healthspan measures across different physiological systems4, these studies 298 
employed cross-sectional designs, and were not suited for an examination of the longitudinal 299 
development of health measures during ageing in individual mice. A principle advantage of 300 
the toolbox here is its simplicity, ready training of investigators, the minimal stress placed on 301 
the animals, and its applicability even to very old mice29. While there has been concern 302 
about phenotyping of mice possibly altering their lifespan, we have found that mice subject 303 
to longitudinal metabolic phenotyping, for example, have a similar lifespan to wild-type 304 
C57BL/6J mice not subject to such studies 6,30,58. Overall, use of the toolbox will speed the 305 
prioritization of possible geroprotectors for further preclinical and clinical testing. 306 
 307 
Experimental design  308 
When testing geroprotectors, a minimum of two groups of mice is required: a 309 
group treated with the geroprotector and a vehicle-treated control group; Treating young 310 
mice is also often desirable to control for effects which are independent of age or may be 311 
detrimental such those seen with rapamycin4,59. When testing genetically modified 312 
animals, there may also be a need to include additional control groups based on how the 313 
mice were generated and the precise experimental question to be answered. Every 314 
intervention should be tested in male and female mice as there are many cases of sexual 315 
dimorphism60-63. In our experience, groups of at least 20 animals per sex are required to 316 
detect physiologically relevant changes in assays included in this toolbox, such as rotarod 317 
performance, glucose tolerance, and grip strength4,6,16,17,31,43,64,65. These have been 318 
obtained using in house and published data on mean and standard deviation for each 319 
test, using biological relevant effect sizes with a power of 80% and alpha of 0.05. We 320 
have considered the same size of effect following exercise, an intervention known to have 321 
positive effects in humans. We recommend that animals be randomly assigned to groups 322 
at the cage level, using computing generated assignment of mice to the treated and 323 
control group and stratified by weight; we typically observe that stratification by weight is 324 
sufficient to match most baseline measures of health in young wild-type animals. 325 
Stratification based also (or instead) on frailty may be considered when group assignment 326 
is performed in aged mice to reduce variability and group size.   327 
We also recommend blinding of the experiments, i.e. that the allocation of the 328 
treatment groups is performed by a different researcher and should not be revealed to the 329 
people conducting the experiment until the data have been analysed. This is particularly 330 
important for tests such as frailty or grip strengths, which are operator dependent. It may not 331 
always be possible as some phenotypes (i.e. mice treated with calorie restriction) are 332 
visually obvious.  333 
For both cross-sectional and longitudinal deaths, it is important to include sufficient 334 
numbers of mice to allow for age-related mortality, particularly after 18 months of age. In 335 
the hands of some of the investigators, female mice on a C57BL/6J genetic background 336 
or from the NIA Aging Mouse Colony experience 30-36% mortality between 20 and 27 337 
months of age (50-66% mortality between 20 and 30 months of age), while male mice 338 
experience 8-18% mortality between 20 and 27 months of age (and 30-36% mortality 339 
between 20 and 30 months of age) (6 and data not shown). The overall mortality rate also 340 
varies based not only on strain and genetic background, but also diet and animal facility; 341 
for example, the NIA’s Intervention Program has found a persistent difference in lifespan 342 
between mice test sites despite standardized mice, diet, and husbandry66. If local data for 343 
the survival of a strain is not available, the mortality between any two ages can be 344 
estimated for many strains using lifespan data published by the NIA and by The Jackson 345 
Laboratory58,67.  346 
Fig. 1 is a schematic representation of the experimental design for testing in 347 
C57BL/6J mice, the frequency of assessment and the type of tests. The sequence with 348 
which the tests are performed is also important and the time in between tests to avoid 349 
stress to the animals as much as possible. We recommend to perform the multiple assays 350 
over a period of 4-6 weeks using the following order, novel object recognition, frailty 351 
index, grip strength, cage top and hanging bar, followed by rotarod, body composition, 352 
energy expenditure, GTT, ITT and echocardiography.  353 
Limitations of the approach  Testing healthspan involves complex experiments, which are 354 
costly and requires an in-depth knowledge of multiple organ systems combined with 355 
knowledge of the ageing process and welfare issues in mice. The protocols described in this 356 
toolbox summarize the knowledge collected from years of experience in the area of 357 
healthspan assessment and murine ageing biology. Their availability will reduce animal 358 
usage and costs by reducing the need to optimize each technique when establishing 359 
healthspan assessment platforms in other laboratories. It will also ensure that the data are 360 
comparable and reproducible across laboratories, speeding up progress.  361 
 362 
Regulatory requirements. These vary in each country and between institutions, and 363 
therefore it is always advisable to check with the relevant veterinary authorities, and gain 364 
regulatory approval as may be required, before performing any procedure. At each 365 
institution, all authors performing any of the described procedures received regulatory 366 
approval and oversight as appropriate.  This included approval/oversight by the UK Home 367 
Office  (IB, PP), the Institutional Animal Care and Use Committee of the William S. Middleton 368 
Memorial Veterans Hospital (DL),  Landesamt für Natur, Umwelt und Verbraucherschutz 369 
Nordrhein-Westfalen, Recklinghausen, Germany (DE), Mayo Clinic Institutional Animal Care 370 
and Use Committee (TT, JDM),  the Committee of Ethics and Animal Experimentation of the 371 
Cajal Institute, Ethics Committee of the CSIC, and the Animal Protection Area of the Ministry 372 
of Environment of the Community of Madrid (JLT), and the Animal Care and Use Committee 373 
of the National Institute on Aging, NIH, US (RdC, CDG, SJM, IN).  374 
 375 
Requirements for staffing, expertise, and equipment. While the majority of the 376 
techniques in the toolbox do not require an abundance of highly specialized staff, training is 377 
required, particularly for the grip strength test and echocardiography. It is advisable that PhD 378 
students and post-docs visit a lab which is running these tests routinely. This is particularly 379 
important for grip strength as this test is highly operator dependent. For echocardiography a 380 
specialized facility and extensive specialized training of staff is required for the acquisition, 381 
analysis and interpretation of the images. Some techniques such as the glucose tolerance 382 
test require a significant investment of hands-on staff time. Likewise, performing several 383 
informative protocols in the toolbox, including determination of body composition, cardiac 384 
function, and energy balance, requires an upfront investment in single-purpose equipment, 385 
and an ongoing commitment to maintain that equipment.  386 
 387 
 388 
Handling of aged mice. Working with aged animals presents additional difficulties when 389 
compared to working exclusively with young animals. Animal care, laboratory, and veterinary 390 
staff should be familiar with the care and handling of aged mice, and be able to distinguish 391 
between an old mouse, a sick mouse and an old, sick mouse. Older mice tend to be less 392 
active, may lose weight, and appear less healthy, and humane endpoints developed for 393 
younger mice may not be appropriate for older mice. With the time, expense and ethical 394 
implications of ageing cohorts of mice it is important that aged mice are not culled 395 
unnecessarily, thus affecting cohort size, or allowed to exceed humane endpoints or ethical 396 
standards. Staff should become familiar with how the strain(s) or line(s) age, their care, and 397 
the treatment of spontaneous phenotypes. The age of breeding stock can have effects on 398 
the offspring13,68-72; therefore knowledge of the age of breeding mice and even limited 399 
phenotyping such as body composition or weight, would be useful metadata. Ideally, the age 400 
of breeding stock would be standardised to minimise variation in offspring. Phenotypic data 401 
in aged mice tends to exhibit a greater variance than that in young mice65, which may reflect 402 
the differences in ageing between individuals, even within inbred strains.  With the increased 403 
variance of data from aged mice the standardisation of protocols down to the finest detail is 404 
critical as is the recording of metadata as small variations can be amplified thus confounding 405 
the output of experiments. This includes time of day of phenotyping and the operator. 406 
 407 
Anaesthesia. The cardiac function protocol requires anaesthesia. Repeated anaesthesia – 408 
as would be required for longitudinal examination of cardiac function in aged mice - has 409 
been suggested to be linked to cognitive impairment in humans. However, repeated 410 
anaesthesia with isoflurane does not result in prolonged cognitive deficits at least in mice 411 
that are approximately 18 months old73. In this toolbox, the animal is euthanized after the last 412 
echocardiography at 24 months of age. Aged animals may also be more likely to have 413 
negative reactions to anaesthesia74-76. 414 
 415 
Timing may vary. Timings and frequency are for ageing C57BL/6J mice, but may vary for 416 
other strains or genetically modified models. For example, it may prove appropriate to begin 417 
phenotyping at an early age for very short-lived mice or for genetically modified mice 418 
expected to begin developing phenotypes at an early age34,44. Conversely, when mice are 419 
expected to develop phenotypes at an advanced age, or an intervention is begun only late in 420 
life, it is likely a more efficient approach to not begin phenotyping mice until later in their 421 
lifespan or immediately prior to the start of an intervention6,47,49.  422 
 423 
Suitability for progeroid mice. Many of the metabolic phenotyping protocols in the toolbox 424 
are not suitable, or are suitable only with modification, for the use of progeroid mice, which 425 
are often small, extremely frail, and prone to hypothermia if singly housed. When using 426 
metabolic chambers, in which animals are single-housed without bedding, some 427 
investigators suggest that animals which may be more sensitive to cold stress be analysed 428 
for a shorter time period than suggested below, typically approximately 24-26 hours, or the 429 
temperature in the room or specifically in the metabolic chamber (if housed in a temperature 430 
controlled cabinet) can be raised to prevent hypothermia. 431 
 432 
Limitations of intraperitoneal administration of glucose. While we have provided 433 
instructions below for performing a glucose tolerance test using glucose administered via 434 
intraperitoneal injection (IPGTT), glucose can also be administered via oral gavage (OGTT). 435 
An OGTT is likely more physiological since glucose is administered orally, and incretin 436 
hormones are engaged. Incretin hormones (GIP and GLP1) are secreted from the intestine 437 
in the blood stream and influence the insulin secretory response and pancreatic beta cells; 438 
they also have effects on glucagon response and fat deposition77-79. If investigators are 439 
specifically asking questions that involve incretins, it is likely they will need to perform 440 
OGTTs. 441 
 442 
However, drawbacks to OGTT include that it needs to be performed by a very well trained 443 
operator to reduce stress to the animals, which may influence the outcome of the study. 444 
Further, in some countries, oral gavage is considered a highly invasive procedure for the 445 
animal and needs to be very well justified for its use. In contrast, IPGTT is a technique that 446 
can be rapidly taught and involves minimal stress for the animals.  Finally, IPGTT and OGTT 447 
provide comparable results in young and aged C57BL/6J mice 80. The majority of our labs 448 
administer IPGTTs unless a specific question requires the use of OGTT. 449 
 450 
Limitations of the novel object recognition task. It involves only a single training 451 
session81,82 and hence it is not possible to resolve potential effects on learning rate which 452 
would require repeated training. It should also be noted that the level of object exploration by 453 
the animals can be low or inconsistent which may require the exclusion of animals in order to 454 
avoid skewing of results. Also, it is necessary to carry out careful pilot studies to ensure that 455 
training period, delay intervals and test duration are optimized for suitable behavioural 456 
performance within a given experimental context. Moreover, one needs to carefully evaluate 457 
all object pairs used in the task to ensure that there is no intrinsic difference in object 458 
exploration by the animals. Conditions should always be counterbalanced to minimize any 459 
effect of differential intrinsic object preference.  460 
The influence of the environment. The standardization of protocols is critical to minimize 461 
variation due to environmental differences or gene-environment interactions. Recent studies 462 
have highlighted how apparently minor differences, including timing, temperature, bedding, 463 
as well as variation in the microbiome can affect the outcome and reproducibility of mouse 464 
experiments83. The experience of the National Institute on Aging’s Interventions Testing 465 
Program has demonstrated that even when mouse source, diet, and husbandry conditions 466 
are intentionally coordinated to be identical, there remain site-specific variations in murine 467 
lifespan84. While these studies demonstrate the difficulty of achieving perfect reproducibility 468 
in experiments conducted at disparate sites, they also demonstrate that by matching known 469 
variables as closely as possible, reproducibility can be enhanced by minimizing differences. 470 
Thus, we encourage investigators to control for those variables that are most likely to impact 471 
the experiment, such as the operator, the testing room, the time of the day, and the 472 
equipment utilized. Some factors such as housing conditions (number of animals per cage, 473 
type of enrichment, and noise) or diet may not always be under the control of individual 474 
researchers because it is determined at an institutional level. These factors should be 475 




Laboratory mice 480 
The procedures described here were primarily developed with mice on a C57BL/6 481 
genetic background (specific variants include but are not limited to C57BL/6J from 482 
The Jackson Laboratory, C57BL/6J from Janvier Labs, C57BL/6N from Taconic 483 
Biosciences, and C57BL/6J.Nia from the National Institute on Aging Aged Rodent 484 
Colony).  485 
 486 
The procedures can be readily carried in healthy animals of a wide range of ages; 487 
cautions regarding risks of specific procedures to old animals (C57BL/6J mice over 488 
approximately 24 months of age) are noted in specific procedures.  489 
 490 
CAUTION: All experiments should be performed in accordance with relevant 491 
guidelines and regulations and approval of the relevant institutional committees. 492 
General reagents 493 
• Cleaning supplies 494 
CRITICAL All of the equipment utilized in the procedures below must be cleaned 495 
after use, using procedures suitable to the equipment and in accordance with both 496 
the manufacturer’s instructions and institutional policies.  497 
• Paper towels 498 
Cardiac function 499 
• Isoflurane for use in isoflurane vaporizer  500 
 501 
CAUTION: Isoflurane is a respiratory depressant and chronic exposure can 502 
negatively impact health, resulting in effects including hypotension, tachycardia, 503 
respiratory depression, and elevated blood glucose level. Isoflurane should be used 504 
in combination with equipment designed to minimize exposure (e.g. vaporizer with an 505 
activated carbon scavenging system), and institutional standard operating 506 
procedures to ensure safe use should be followed. 507 
 508 
• Medical Oxygen (e.g. BOC) or Air source for isoflurane vaporiser  509 
• Conductive electrocardiography (ECG) Gel  510 
• Aqueous medical ultrasound gel (e.g. AquaSonic) 511 
• Micropore Tape (e.g. 3M) 512 
• Electric small animal hair clippers 513 
• Hair removal lotion (Veet) 514 
Energy Balance 515 
• Respiratory gasses. Gasses for the calibration of the O2 and CO2 sensors will be 516 
specified by the equipment vendor, but must be ordered from gas vendors. 517 
Glucose tolerance test 518 
30% glucose: Prepared by dissolving 30% (30g/100mL) glucose (G7021, 519 
MilliporeSigma) and 0.9% NaCl (S5886, MilliporeSigma) in high purity water, and 520 
then filter-sterilized using a 0.2µM filter (430626, Corning) and ~10mL aliquoted into 521 
15mL tubes (12565268, Fisher Scientifici). Aliquots may be stored at 4°C or frozen at 522 
-20°C. This solution should be prepared at least one day prior to the assay. 523 
CRITICAL: 30% glucose must be prepared for the treatment of any mice that develop 524 
hypoglycaemia during the insulin tolerance test also. 525 
•  526 
• Syringe: 1mL sterile disposable syringe (309659, Becton Dickinson) – one syringe is 527 
required per mouse 528 
• Needle: 27G1/2 sterile needle (305109, Becton Dickinson) – one sterile needle is 529 
required per mouse. 530 
CRITICAL: The procedure described here is an intraperitoneal (I.P.) glucose 531 
tolerance test. As discussed in the limitations above, some investigators, particularly 532 
those investigating incretins, will prefer to perform an oral glucose tolerance; in such 533 
a case, an oral gavage needle is required instead. 534 
• Glucose test strips: Bayer Contour Blood Glucose Test Strips (Various) – six glucose 535 
test strips per mouse are required; extra glucose test strips in case of mishaps, 536 
misreads, or defective test strips is a good idea 537 
• Razor blades: 55411050 (Andwin Scientific via VWR) – one razor blade per mouse 538 
cage 539 
• Spreadsheet: One or more datasheets per experimenter, with space for entering the 540 
weight, volume of glucose to be administered, blood glucose levels at each of six 541 
time points, and room for other notes.  542 
• EDTA Blood Collection Tubes: 20.1288.100 (Sarstedt Inc via Fisher) CRITICAL 543 
Required if also collecting blood for insulin or other hormone measurements. 544 
• Insulin ELISA Kit: 90080 (Crystal Chem) CRITICAL Required if also collecting blood 545 
for insulin or other hormone measurements. 546 
 547 
Insulin tolerance test 548 
• Insulin: Prepared by diluting 22.5uL of sterile 100U/mL Humilin-R (Lily) in 10mL of 549 
filter-sterilized (using a 0.2µM filter (430626, Corning)) 0.9% NaCl.  550 
CRITICAL: Do not use long-acting insulins.  551 
CRITCIAL: Diluted insulin does not retain activity indefinitely, and must be freshly 552 
prepared (within ~2 hrs of use). Do not filter insulin after dilution.   553 
 554 
Grid hanging test 555 
• Spreadsheet with a list of mice, with space for entering the weight and the time to fall 556 
for up to three attempts. 557 
 558 
EQUIPMENT 559 
General equipment 560 
• Marker – A black or other dark color marker capable of temporarily marking the tail of 561 
mice, e.g. 52877-310 (VWR). 562 
• Scale – an electronic balance with sensitivity to at least 0.1 g. Some of us use an 563 
Ohaus SP-402 Scout Pro Balance (Various), but many brands are available. 564 
• Timer – A lab or kitchen style timer that can count upwards from zero while 565 
displaying both minutes and seconds, e.g. 76204-504 (VWR).  566 
• Weighing container – a glass or plastic container of 300-500mL volume for placing 567 
mice in while being weighed.  568 
Cardiac function 569 
• Inhaled anaesthesia system with small nose cone to allow easy access to thoracic 570 
area with transducer. 571 
• Vevo 770 / 1100 / 2100 / 3100 System with the recommended transducer for the 572 
specific system used, e.g. the MX550D (32-55 MHz linear array) for mice with the 573 
Vevo 3100 system. Lamp (e.g. 250 Watt Infra-Red warming bulb) to maintain body 574 
temperature. 575 
• Gel warmer (available from Visualsonics) or 37°C waterbath to ensure gel is warmed 576 
to body temperature. 577 
Cognitive function 578 
• A dedicated room big enough to allocate a 42 x 32 x 31 centimetre arena and for the 579 
experimenter to move freely around the cage with access to a computer. The 580 
behavioural room should be in proximity to the place where the animals are housed 581 
to limit stress associated with transportation of the mice. A video camera attached to 582 
the ceiling, thus providing overhead footage on the very centre of the arena and 583 
connected to the computer.  Room lights should be indirect or at least located in a 584 
way that no reflection appears in the area to be tracked and should preferably be 585 
adjustable in brightness, as illumination should be around 150 lux at the floor of the 586 
arena. 587 
CRITICAL: One of the most damaging distractions in the behavioural laboratory is 588 
unexpected noise, which should be avoided. Similarly, the room environment should 589 
be free from interference by external or internal lights or odours. A running air purifier 590 
(e.g. Honeywell True HEPA Air Purifier 50250) in the testing room can be used to 591 
generate a constant low level of white background noise to help to mask unexpected 592 
external noise sources.  593 
• An open wooden or methacrylate box of 42 x 32 x 31 centimetres used as an open-594 
field arena. Although novel object recognition performance has not been directly 595 
compared across boxes with different dimensional characteristics, this is unlikely to 596 
impact the result of the test. Indeed other mouse behavioural measures in an open 597 
field setting have been found to be insensitive to different box dimensions 85.The box 598 
should not be covered with sawdust and should be located on the floor or on a table. 599 
• Small plastic objects, e.g. toys or cans. We use objects sized 5 x 5 x 5 cm but a 600 
variety of object dimensions can be used. The objects should not have mobile parts 601 
and must be easy to attach and remove from the floor of the arena (usually by means 602 
of an adhesive tape). They should be located around the centre of the arena, in an 603 
opposite and symmetrical way (see below). 604 
• CRITICAL: It should be established empirically for all pairs of objects to be used for 605 
the assessment of novel object recognition that they induce indistinguishable levels 606 
of exploratory behaviour when encountered for the first time by animals of the 607 
specific mouse strain used for experimentation. Objects should be sufficiently distinct 608 
for successful discrimination, yet similar enough (e.g. with regards to size, shape, 609 
presence of protrusions/intrusions, texture, brightness) to avoid inherent preference 610 
biases for one of the objects within the object pair. For further consideration of object 611 
feature influences on the performance in novel object recognition tasks, see 86,87. 612 
•  A computer connected to an overhead video camera and able to run commercially 613 
available animal behaviour tracking software. The software needs to be able to track 614 
the animal in the arena, by a multiple body points tracking system, and based on the 615 
tracking data, compute time spent, as well as distance travelled in different user-616 
defined sections of the arena, considering the nose point and center point of the 617 
animal separately23. We use Ethovision XT (Noldus) or Smart video tracking software 618 
(Panlab). Video footage should be provided for potential additional analyses. Careful 619 
arrangement of the environment of the behaviour room should be observed 620 
(especially illumination). This should follow the instructions by the software 621 
manufacturer, to assure adequate tracking of the animals’ nose point. We 622 
recommend the use of automated video tracking. While manual scoring may be 623 
necessary in some circumstances, the process is labour-intensive and the exact 624 
determination of whether the nose point is in the target area is more subjective23. For 625 
automated video tracking, it is critical to maintain continuity of nose tracking. This can 626 
be easily achieved with careful illumination combined to adequate contrast detection 627 
parameters allowed by the software. 628 
Body Composition 629 
• A variety of systems are available such as the EchoMRI-700 system with an A-100 630 
insert antenna, which enables the measurement of animals  up to 100g of body 631 
weight, and the Bruker's minispec Whole Body Composition Analyzer LF90.  632 
CRITICAL: While any system based on nuclear magnetic resonance (NMR) can be 633 
utilized, dual-energy X-ray absorptiometry (DXA) based body composition analysis is 634 
not preferred, as anaesthesia is required, DXA uses a small dose of ionizing 635 
radiation, the length of procedure is longer, and NMR is more accurate than DXA for 636 
the determination of both fat mass and lean mass11. However, if a laboratory only has 637 
access to DXA, the investigator will need to balance these factors vs. the need to 638 
acquire body composition data.  639 
• An animal holder, sized appropriately to the weight of the animal. A tube sized for 640 
mice of approximately 40g (e.g., EchoMRI part 600-E25130R-40) is appropriate for 641 
the majority of longitudinal healthspan studies in wild-type mice.    642 
Energy Balance 643 
• A metabolic chamber system equipped to measure food consumption, spontaneous 644 
activity, and respiratory gasses (O2 consumption, CO2 production). The 645 
Oxymax/CLAMS (Comprehensive Lab Animal Monitoring System) manufactured by 646 
Columbus Instruments is the most commonly used, but alternative and functionally 647 
equivalent systems are also available from other vendors, e.g. TSE Systems or 648 
Sable Systems. Other options are available, including measurement of water intake, 649 
running wheels (to assess voluntary activity), urine collection, and temperature 650 
telemetry. Some systems can also assess respiratory gasses during forced running 651 
with the use of a treadmill. 652 
 653 
CRITICAL: The system should be installed in a location where disturbances from 654 
animal facility staff and laboratory personnel is minimal, ideally in a room not used for 655 
the housing of other animals and not routinely entered by others while the chambers 656 
are in use. The system can be installed in an optional environmental chamber, which 657 
we highly recommend as it aids in the isolation of the animals from external stimuli. In 658 
particular, it permits finer control of temperature and lighting than is typically possible 659 
in an animal facility, and places it under computer control.  660 
 661 
• Food processor – if the metabolic chamber system has a feeder that dispenses 662 
ground food rather than pellets, a commercial food processor to pulverize pelleted 663 
feed into a powder is extremely convenient. Many different options are available such 664 
as the Hamilton Beach 12-Cup Stack and Snap Food Processor (#70725A, Amazon). 665 
Small quantities of food may also be pulverized by hand using a mortar and pestle. 666 
Glucose and insulin tolerance tests 667 
• Glucometer – a human glucose meter capable of utilizing the test strips purchased in 668 
reagents such as a Bayer Contour Blood Glucose Meter (Various), but many brands 669 
are available 670 
CRITICAL: Different models of glucometers consistently produce slightly different 671 
blood glucose readings. As a consequence, all strips and glucometers used during 672 
an assay should be of the same brand and model. 673 
 674 
Grid hanging test 675 
• The apparatus used can basically be as simple as a metal cage top from the home 676 
cage of the mouse or any other kind of mesh/grid (squares no bigger than 1cm x 677 
1cm) that allows the mouse to grip and hang upside down. 678 
Grip strength 679 
• A Grip Strength Meter – similar and functionally equivalent grip strength meters are 680 
available from several vendors, including Columbus Instruments (e.g., 1027CSM, 681 
Single Computerized Sensor with Standard Pull Bars for Mice) and Harvard 682 
Apparatus (e.g., Bioseb Grip Strength Meter). 683 
Hanging bar 684 
• Hanging bar apparatus - A 50 cm wide, 2 mm thick metallic wire tightly secured 685 
between 2 vertical stands approximately 37-50 cm above a layer of bedding. 686 
Rotarod 687 
• A variable speed, accelerating rotarod –e.g. Columbus Instruments (e.g., 0890M, 688 
Rotamex-5 4 Lane Rota-Rod for Mice with RS-232 and Software) but similar 689 
equipment is also available from a variety of vendors.  690 
PROCEDURE 691 
Methods for assessment of cardiac function 692 
1. Place ultrasound gel in the gel warmer. 693 
2. Turn on the ultrasound machine.  Enter animal ID, date and time, and other 694 
relevant information, including body weight, age and experimental intervention (if 695 
any). 696 
CRITICAL: Use high frequency ultrasound transducer appropriate to the size and 697 
weight of the animal; e.g. a 40 MHz transducer for imaging mice less than ~20 grams 698 
or a 30 MHz transducer for mice weighing more than ~20 grams.   699 
CRITICAL:  In order to maintain normothermia during the imaging session, turn on 700 
the warming mechanism on heated platforms, as well as an ancillary warming lamp if 701 
the room temperature is cool (e.g., < 72°F/22°C).  It is helpful to have a warming 702 
lamp and heat pad also focused on the cages used for recovery (with mice 703 
recovering on a paper towel in an otherwise empty cage) to prevent hypothermia and 704 
accelerate recovery.  Turn these devices on at this time as well.    705 
CRITICAL:  Ensure that all hardware/tubing for scavenging of isoflurane gas is 706 
connected/intact, functional, and turned on (e.g., suction for active scavenging if 707 
present).    708 
3. Gently pick up the mouse by the tail and firmly grasp the animal by its nape. 709 
Quickly and accurately insert the animal’s nose and mouth into the nosecone and 710 
begin administration of 2-3% isoflurane.  Once anesthetized (10-30 seconds), lay 711 
the animal on the platform in supine position making sure the forefeet and 712 
hindfeet lay on the ECG sensors of the platform.   713 
CRITICAL:  Methods for induction of anaesthesia are a major source of variability when 714 
imaging rodents.  If you are using an “induction box” prior to placement of the mouse on 715 
the platform/nosecone, be sure to standardize the concentration of isoflurane used for 716 
induction and use the animal’s individual response to anaesthesia (i.e., immediately 717 
upon immobilization and clear ability to be transferred safely to platform) rather than a 718 
fixed period of time for induction.   719 
4. Gently secure the animal with adhesive tape on all four limbs and the tail, and 720 
lightly also apply adhesive tape to stabilize the head in the nose cone apparatus. 721 
5. Check heart rate (HR). Ensure that the baseline HR in is between 500 to 700 722 
bpm.  723 
CRITICAL: Ensure that the HR does not fall below 450 bpm under any 724 
circumstances.  Should HR fall below 450 bpm, progressively reduce anaesthesia by 725 
0.1% increments every 15 seconds until HR recovers.  If HR does not recover and/or 726 
continues to decrease, immediately remove the animal from the nose cone and 727 
transfer to a warming pad for recovery.   Adjust anaesthesia flow by small increments 728 
accordingly (~0.1 % increments every 15 seconds) until a stable state of anaesthesia 729 
is reached. While the final level of anaesthesia can vary based on the type and 730 
design of the isoflurane delivery/evacuation system used, experienced imaging 731 
personnel can successfully acquire data using level of isoflurane as low as 0.8% 732 
(with commonly used ranges of 1.0-1.5%).  Critically, this should not be a 733 
standardized level but tailored to the physiological response of each animal to 734 
anaesthesia.  Also, this should be an “imaging plane” of anaesthesia (responsive to 735 
toe pinch, no cardiorespiratory depression), not a “surgical plane” of anaesthesia 736 
(non-responsive to toe pinch, often cardiorespiratory depression). 737 
TROUBLESHOOTING:.     738 
6. Place ECG gel on contact pads, with a narrow strip of tape to attach the back of 739 
the fore paws to the contact pads and the pads of hind paws to the contact pads. 740 
7. Insert temperature probe in rectum and tape in place. Document baseline body 741 
temperature and ensure that the warming lamps and platform are sufficient to 742 
maintain body temperature throughout initial imaging sessions (particularly after 743 
shaving).   744 
8. Shave off hair on chest using an electric clipper designed for use with fine hair.  745 
Wipe clean chest with a damp paper towel. Clip fur from the top of the sternum 746 
down to the xiphoid process then down either side of the rib cage. Shaving lotion 747 
may be used if helpful.  748 
9. Cover clipped area with hair removal lotion, leave for 30 seconds to a minute for 749 
mice. Remove lotion with warm wet swabs. 750 
CAUTION: Make sure all hair removal lotion is removed as chemical burns will form if 751 
any is left. 752 
10. Apply a generous amount of warmed ultrasound gel on the transducer or directly 753 
on the animal’s chest. 754 
11. Position the transducer parasternally about 90 degrees perpendicular with the 755 
long axis of the heart with image index marker of the transducer pointing 756 
posteriorly. While in B-mode, slide the transducer cephalad until the aortic valve 757 
(AV) comes into view.  758 
 759 
TROUBLESHOOTING:  760 
12. Press the color Doppler control key in the control panel. Apply color Doppler to 761 
region of the aortic valve and carefully sweep back and forth across the aortic 762 
root to observe for aortic valve regurgitation (mosaic-patterned, high velocity jet in 763 
the ventricle during diastole) or stenosis (mosaic-patterned, high velocity jet 764 
during systole).  Importantly, neither of these phenotypes generally emerge with 765 
chronological aging in mice.  766 
13. Place the transducer in the apical position in the B-mode. Position the transducer 767 
so that it is angled towards the head of the mouse Observe the right ventricle 768 
(RV), left ventricle (LV), right atrium (RA) and left atrium (LA) on the image 769 
display. 770 
From the apical 4-chamber view, bring the mitral valve in focus by reducing the 771 
image width.  772 
14. Using the apical 4-chamber view, apply color Doppler to image flow from the left 773 
atrium through the mitral valve during diastole. Observe for mitral valve 774 
regurgitation. 775 
15. From the apical long axis view, tilt or point the transducer tip with a rocking 776 
motion so that the right ventricle is at the center of the image display. Reduce the 777 
image width so that only the right ventricle is visible in the image display.  778 
16. Apply colour Doppler in the region of the tricuspid valve. Observe for tricuspid 779 
valve regurgitation. 780 
17. Move the transducer in the parasternal position at the level of aortic valve. 781 
Observe the pulmonic valve in the parasternal short axis views.  782 
18. Rotate the transducer clockwise to a modified parasternal long axis position. 783 
Then tilt the transducer slightly upward to obtain a short axis view of the pulmonic 784 
valve. 785 
19. Apply colour Doppler in the region of the pulmonic valve to assess for valvular 786 
regurgitation (mosaic-patterned, high velocity jet during diastole) and stenosis 787 
(mosaic-patterned, high velocity jet during systole). Importantly, neither of these 788 
phenotypes generally emerge with chronological aging in mice  789 
20. Obtain short axis view of the LV in B-mode with the transducer in parasternal 790 
short axis position at the level of papillary muscles. 791 
21. From a parasternal short axis view of the left ventricle, press the M-mode button 792 
located in the control panel. Using the track ball, position the M-mode cursor at 793 
the level of the papillary muscles, and obtain M-mode images.  794 
22. Measure left ventricular cavity dimension at end-diastole where the distance 795 
between the anterior wall and posterior wall is largest, and in end-systole where 796 
inward motion of the both anterior and posterior walls is maximum   797 
23. Place the transducer in B-mode imaging modality and move the transducer to the 798 
apical window (make sure the transducer is angled towards the head of the 799 
mouse). Often times, placing the platform so that the animal is in a slight “head 800 
down tilt” can facilitate image acquisition from this window.  801 
24. Place sample volume at the tips of the mitral valve leaflets. Derive the isovolumic 802 
relaxation time, isovolumic contraction time, left ventricular ejection time and peak 803 
mitral inflow velocity from the spectral display of pulsed-wave Doppler velocities 804 
across the mitral valve  805 
25. Perform tissue Doppler imaging (TDI) of the mitral annulus in the apical long axis 806 
view. Press the TDI control key and place sample volume at the medial aspect of 807 
the mitral annulus. Make sure that the sample volume does not encroach on the 808 
mitral leaflets. Keep Doppler sample volume size between 0.21 mm to 0.27 mm. 809 
Measure early diastolic velocity (e’) of the mitral annulus.  810 
CRITICAL: Review acquired images. Ascertain that all required images were 811 
obtained. 812 
26. Remove the animal from anaesthesia and place the animal on an absorbent 813 
paper towel (not bedding, which can be aspirated/block airways during recovery). 814 
Observe the animal until sternal recumbency is attained. If the anaesthesia is 815 
administered appropriately, recovery should occur within 30 to 60 seconds.  816 
 817 
Assessment of cardiac function. 818 
CRITICAL: Generally speaking, high resolution echocardiography systems designed for use 819 
in small animals have multiple tools that facilitate calculation of cardiac function parameters.  820 
Consequently, this section will focus predominantly on critical aspects of post hoc analyses 821 
that are central to the acquisition of reproducible cardiac function data.   822 
 823 
27. Ejection fraction, systolic function, and ventricular wall thickness from M-mode 824 
(Figure 2A).  We typically assess ejection fraction from M-mode images (step 825 
21), as the data tend to be more reproducible and less affected by subtle 826 
alterations in probe orientation and/or ventricular movement/orientation 827 
throughout the cardiac cycle.  For assessment of cardiac dimensions and 828 
automated calculation of ejection fraction, measure distance between the anterior 829 
and posterior ventricular walls at its largest point during end-diastole, and at its 830 
smallest point at end systole.  Subsequently measure the anterior and posterior 831 
wall thicknesses at end systole and end diastole.  While it is essential to use the 832 
papillary muscles as an anatomical landmark to ensure an appropriate imaging 833 
plane (which should be assessed on each M-mode measurement), it is critical to 834 
exclude them from any measurements of ventricular dimension or wall thickness.  835 
When possible, it is ideal to take 5 or more measurements during consecutive 836 
cardiac cycles to ensure accuracy of the data. 837 
28.  838 
 839 
a.    840 
Assessment of diastolic function using pulsed-wave Doppler measurements (Figure 841 
2B, C).  We generally do not assess diastolic function using E/A ratios due to the 842 
fusion of these two peaks at physiological heart rates in mice.  Our preferred method 843 
is to use the E/e’ method, which is derived from the blood and tissue Doppler images 844 
acquired in steps 24-25. It has also recently been shown that isovolumic relaxation 845 
time (IVRT) can serve as an additional tool to detect changes in diastolic function in 846 
the diseased hearts of young mouse models of diastolic dysfunction88. Given the high 847 
degree of context dependence of most models (and the general lack of validation in 848 
models of chronological aging to date), we strongly recommend the acquisition of at 849 
least two measurements of diastolic function (e.g., E/e’ and IVRT) in studies of aging 850 
mice.  Future work assessing the utility and validity of other variables in detecting 851 
subclinical and overt diastolic dysfunction (e.g., peak longitudinal strain rates, etc.) 852 
will be essential to advancing the field of biogerontology.  For assessment of peak 853 
mitral inflow velocity (E), open the apical long-axis view of the mitral valve acquired in 854 
step 24.  Place the sample volume for the pulsed-wave Doppler at the tips of the 855 
mitral valve leaflets and acquire the spectral display over several cardiac cycles. 856 
Measure the peak inflow velocity, and if desired, the isovolumic contraction, 857 
isovolumic relaxation, and ejection times for the left ventricle. For assessment of the 858 
septal mitral annulus tissue velocity (e’), place the Doppler sample volume 859 
(approximately 0.21-0.27 mm) at the septal region of the mitral annulus.  Be sure that 860 
the sample volume does not encroach on the mitral leaflets.  Measure and record the 861 
tissue velocity.   862 
Cognitive function 863 
CRITICAL This novel object recognition test is based on the one developed by 864 
Ennaceur and Delacour81 and adapted from the protocol by Leger et al.82. This assay is of 865 
special translational interest given existing implementations for rodents and humans90. The 866 
test described here uses the recognition and association of salient cues, specifically the 867 
comparison between similar but not equal objects, in order to recognize which of the objects 868 
is already known and which one is novel. By adjusting the number of cues, the salience of 869 
cues, and the time allowed to learn and to memorize the information provided, the test can 870 
efficiently be adapted to mice of different ages and genetic background. In the same way, by 871 
adequately changing the type, form, and brightness of the objects in the object recognition 872 
test, the test can be adapted to be performed more than one time.  873 
 874 
1. Before the assay.  Plan the experiment by considering the sex of animals and the 875 
time of day behavioural assays will be undertaken. Identical procedures can be used 876 
on both male and female mice91. Notably, while it has previously been thought that 877 
female performance is sensitive to the phase of the estrous cycle, recent analyses 878 
have found that female variability when studied without regard for the estrous phase 879 
is actually not any greater than male variability; thus, female mice may be studied 880 
without monitoring of the estrous cycle92-94. Most laboratories perform behavioural 881 
tests during the daytime, which is the resting time for mice. We recommend that 882 
behavioural experiments are executed during the daytime, but avoiding the period of 883 
time leading up to the end of the light period when the animals start to become more 884 
active. The preferred time to perform the behavioural analysis is between 9 am 885 
(approximately two-three hours after the end of the dark cycle) and not after 886 
approximately 4-5 pm (the two hours leading up the beginning of the dark cycle). 887 
  888 
  889 
2. Ensure animals have been handled as this decreases stress and anxiety induced by 890 
contact with the investigator.  The experimenter can handle the animals while 891 
moving them from an old to a new cage every day over the course of two-three 892 
days. Gently take the animal by its tail (being careful not to suspend by the tail for 893 
too long) and place the animal with one hand on the experimenter’s arm covered 894 
with a waterproof sleeve, or alternatively on a paper towel in your gloved hand, for 895 
15 s. Once all of the animals in one cage have been handled once, repeat in the 896 
same order 5 more times. It is also recommended that the animals are labelled by 897 
marking the tail. 898 
3. For aged mice, determine visual acuity as the protocol below relies heavily on the 899 
vision of animals, and aged animals may suffer from blindness or reduced vision. 900 
Consequently, it is mandatory to perform a short visual discrimination test prior to all 901 
stages of the longitudinal analysis. Protocols for visual discrimination test for ageing 902 
mice can be found elsewhere; we recommend the efficient visual discrimination test 903 
for ageing mice described by Brooks and colleagues95, which is based on the 904 
animal’s normal ability to discriminate between bright and matte objects. Animals 905 
showing significantly reduced vision compared with the group mean should not be 906 
utilized for the remaining stages of the longitudinal analyses. 907 
4. Prepare the arena and objects by cleaning with an ethanol solution (70%). If a 908 
methacrylate arena is used, no alcohol should be used, but a soft detergent solution. 909 
This step must also be carried out between all trials to avoid animals being 910 
influenced by the scents of previously tested mice.  911 
 912 
5. Prepare software. Most software requires the experimenter to draw or locate 913 
predefined areas into the arena, which will consist of small areas around both novel 914 
and known objects. We consider the mice exploring objects when their nose point, 915 
but not their center point23, is within a predefined area with a distance equal to or 916 
less than 2 cm from the object81. The maximum time for each trial will need to be set 917 




CRITICAL Ensure that one specific object is not used only as the novel object or 922 
as the familiar object. Change the use of each object within a pair, such that each 923 
object is equally used as novel object or familiar object within each experimental 924 
group. Similarly, one specific side of the box should not contain always the novel 925 
or the familiar objects. However, the assigned locations of the objects during 926 




6. Habituation and training.  To Habituate the animals, place the animals in the room 931 
for at least 30 minutes prior to commencing habituation to the arena. Then allow 932 
animals  to explore the open-field arena freely individually in the absence of objects 933 
for five minutes23,96. Note that center occupancy measures in the open field arena 934 
during habituation can be used to gauge stress- and anxiety-related behaviours in 935 
the mice 97. Remove the animals  and place  back in their home cage. 936 
7. The day after habituation, place two identical objects (objects A and A) in the arena.  937 
Individually introduce the animals  into the open-field arena facing one of the corners 938 
and allow the animal to explore the objects freely (for five-fifteen minutes depending 939 




  944 
 945 
TROUBLESHOOTING:  946 
 947 
CRITICAL:  The time spent exploring the objects will greatly impact the efficiency 948 
with which the animal is able to recognize new objects subsequently. This influences 949 
the discrimination index (DI, see below for definition), and allows the experimenter to 950 
adjust the difficulty of the test according to the age, mouse strain, and model of 951 
ageing. In the same way, the time between training and test phases can be adjusted 952 
to modify the difficulty of the task. It is highly recommended to establish in a pilot 953 
study how normal ageing and/or geroprotectors may affect novel object recognition in 954 
the experimenter’s specific mouse model. Special attention should be paid to the time 955 
between training and test phase, and the time allowed to explore the objects. The 956 
shorter the time allowed to explore, and the longer the delay between training and 957 
test phases, the more difficult the test. This timing can then be used as a reference, 958 
adjusting the difficulty of the test to the specific mouse model and the intervention. 959 
 960 
8. Test phase.– Introduce each animal into the open-field arena containing a known 961 
object (object A) and a novel object (object B) and allow the animal to explore them 962 
freely for 10 minutes. Return all animals to their home cage after the test.CRITICAL 963 
To assess short-term object recognition memory (STM), perform the test  one hour 964 
after the training phase. To assess long-term object recognition memory (LTM), 965 
perform the test  24 hours after the training phase or repeat the test with a different 966 





TROUBLESHOOTING:  972 
 973 
CRITICAL: At different times after the first test phase, new objects can efficiently be 974 
included as new unfamiliar objects, thereby permitting a longitudinal analysis of the 975 
cognition abilities of the animals. However, the DI will not be exactly comparable to 976 
those obtained at the first time, as prior experience with the testing environment (the 977 




Metabolic Health Body Composition assay 982 
 983 
1. Plug the EchoMRI machine  in at least 24 hours prior to the assay in order to charge 984 
the magnet. 985 
2. Calibrate the machine following the manufacturer’s protocol. 986 
CRITICAL: The manufacturer advises (and we have noticed) that the presence of 987 
large masses of metal near the machine will interfere with (and may prevent) 988 
calibration, and may decrease the accuracy of measurements. The machine must be 989 
positioned away from large metal objects, including heavy metal tables, chairs, and 990 
gas cylinders. 991 
3. Using a scale, weigh each animal.  992 
4. Place awake mice into an appropriately sized holder, sliding the adjustable barrier to 993 
minimize the area of movement for each animal.  994 
CRITICAL: The mouse needs to be snug, but should not be held tightly. The 995 
investigator should not attempt this procedure with progeroid mice or aged mice that 996 
are visibly frail unless the scientific goals of the project absolutely require it.  997 
5. Measure whole body fat mass, lean mass, and (if desired) water mass using the 998 
instrument in accord with the standard operating procedure for the machine. We 999 
typically take duplicate one-minute measurements on each animal, omitting the water 1000 
stage. CRITICAL: While scanning, the investigator should ensure that the sum total 1001 
fat mass, lean mass and water mass measured is within ~5% or less of the body 1002 
weight of the animal determined using a scale. If not, the investigator should re-1003 
calibrate the machine, ensuring metal objects are not nearby, and repeat the scan; if 1004 
this does not solve the problem, the machine may need to be serviced. 1005 
6. Average the measurements from the duplicate readings, and express lean, fat and 1006 
water mass data either as an absolute quantity (mass in grams) or as a percentage 1007 
of total body weight. 1008 
 1009 
 1010 
Metabolic Health Energy Balance Assay 1011 
1. Arrange a room containing only the metabolic chambers in which the mouse can be 1012 
undisturbed for two to three days.   If arranging a room containing only the chambers 1013 
is not possible, running experiments when no cage changes are schedule to occur 1014 




2. Turn on the system– ideally for an hour – in order to equilibrate to the desired 1019 
temperature and to remove humidity within the tubing and chambers.  1020 
3. As water vapor needs to be removed from the air before it is flowed over the O2 and 1021 
CO2 sensors, check the water vapor removing system, which differs between 1022 
systems. Some systems may need a desiccant (e.g. Drierite) replenished or a 1023 
condensation trap emptied. 1024 
4. Calibrate the system  (following the manufacturer’s instructions), using cylinders of 1025 
gas with known concentrations of O2 and CO2. 1026 
5. Fill feeders and water bottles. 1027 
•  1028 
 1029 
•  1030 
 1031 
6. Weigh each animal. If desired, also determine  body composition  prior to placing 1032 
mice into the chamber to enable normalization to lean mass instead of body weight. 1033 
7. Place one mouse into each chamber, sealing it according to manufacturer’s 1034 
instructions, and entering the mouse ID and weight into the control program’s 1035 
software. 1036 
CRITCAL: If multiple chamber runs are to be combined, do not always load mice of 1037 
the same group into the same chamber(s) each time. Randomize mice such that 1038 
genotypes and sexes are evenly distributed. This eliminates any biases resulting 1039 
from individual chamber differences (e.g. in noise or lighting). 1040 
8. Run the chambers, checking the availability of food and water once per day. As mice 1041 
are being temporarily single housed in the new environment of the metabolic testing 1042 
chamber, a degree of habituation is required. Typically, discard data collected during 1043 
the first 24 hours of chamber time to account for this acclimatization.  1044 
 1045 
CRITICAL STEP: When checking on the animals the first day, the data from the 1046 
habituation period should be visually inspected to ensure proper functioning of the 1047 
machine. In particular, the O2 in, CO2 in, O2 out, and CO2 out values and the RER 1048 
should be checked to ensure that gas concentration values are fluctuation as 1049 
expected and the RER values are physiologically reasonable. 1050 
 1051 
Glucose tolerance test 1052 
1. Fast the mice by placing them in new, clean cage with ad libitum access to water, but 1053 
without food. The length of this fast – and the time of day the experiment is 1054 
performed – depends upon the question being asked. If primarily interested in 1055 
pancreatic beta cell function, a short daytime fast of 6 hours is sufficient. However, if 1056 
interested in hepatic glucose metabolism and insulin sensitivity, a longer overnight 16 1057 
hour fast should be performed. As the longer fast provides more information, and the 1058 
short-term fast is often more variable and uninformative as C57BL/6J mice do not 1059 
have an age-dependent decrease in beta cell function99, most aging researchers are 1060 
best served by performing an overnight fast for 16 hours. The 16h fast should start in 1061 
the evening (approximately 4-5 PM local time), with the glucose tolerance test 1062 
performed the following morning, approximately 16 hours later (approximately 8-9 1063 
AM local time). If a short fast is performed, the fast should start as soon as the light 1064 
cycle starts (approximately 6 AM local time), with the glucose tolerance test 1065 
performed 6 hours later. Special challenges are posed by studies involving once-a-1066 
day feeding such as calorie restriction (CR). While there is no perfect answer, if an 1067 
overnight fast is to be performed, the CR animals should be fed prior to lights out 1068 
(approximately 4pm). As CR animals typically consume their food within 2 hours, 1069 
both CR and ad libitum fed animals will therefore be fasted for approximately 16 1070 
hours the following morning. 1071 
CAUTION: Fasting aged mice overnight (as for a glucose tolerance test) can be 1072 
stressful, and should be avoided in aged mice (for C57BL/6J mice, we define this as 1073 
male mice over 30 months of age and female mice over 28 months of age). We 1074 
recommend ceasing routine glucose tolerance tests after approximately 24 months of 1075 
age. 1076 
CRITICAL: The bedding should not be caloric; we recommend aspen bedding. The 1077 
use of commercial sterile water gels (e.g. hydrogel) instead of water bottles is 1078 




2. Move the mice to the procedure room for acclimatization at least one hour prior to the 1083 
start of the glucose tolerance test. During this time period, you can continue to work 1084 
preparing the room and the mice (steps 3-5 below), but unnecessary noise should be 1085 
avoided. Weigh each mouse, marking the tail of each animal with a sharpie or similar 1086 
marker such that each animal can be readily distinguished from its cage mates 1087 
without picking it up. 1088 
 1089 
3. Calculate the volume of glucose in µL to be administered to each mouse. Using 30% 1090 
glucose, a dose of 1g/kg of glucose can be rapidly calculated by dividing the body 1091 
weight in grams by 30, and then multiplying by 100 (Example: (30 g mouse/30) x 100 1092 
= 100µL). Enter this value on the spreadsheet. 1093 
4. Prepare one syringe for each mouse. For either an I.P. or oral glucose tolerance test, 1094 
attach the appropriate needle, load a 1mL syringe with more than the required 1095 
volume of glucose, and then remove all bubbles and extra volume from the syringe.  1096 
5. To begin the glucose tolerance test, pick up the first mouse, and make a transverse 1097 
nick across the tail using the edge of a fresh razor blade.  1098 
6. Immediately collect a fresh drop of blood with a new glucometer test strip.  1099 
7. Gripping the mouse firmly, administer the glucose and start the timer, which will 1100 
count upwards from 0. Return the first mouse to its cage. 1101 
8. Proceed to each mouse in sequence, nicking the tail, collecting a fresh drop of blood 1102 
with a glucometer test strip, and administering glucose as in steps 6-7. For each of 1103 
these subsequent mice, note the time of injection of glucose for each mouse on the 1104 
spreadsheet. 1105 
TROUBLESHOOTING:  1106 
9. Determine glucose levels in each mouse 15, 30, 45, 60, and 120 minutes after 1107 
glucose administration. I.e. when the timer reads “15:00”, it is time to take a second 1108 
reading from the first mouse that was injected.  1109 
CRITICAL: It is important to collect a fresh drop of blood that is not contaminated with 1110 
blood from the previous time point; this can be readily achieved by wiping the surface 1111 
of the tail and then gently stroking the tail until a fresh drop is released.  1112 
10. At the end of the assay, ensure that bleeding has stopped in the mice. In rare cases, 1113 
use of a silver nitrate pencil or styptic powder may be necessary to stop the flow of 1114 
blood.  1115 
 1116 
Insulin tolerance test 1117 
1. Fast the mice by placing them in new, clean cage with ad libitum access to water, but 1118 
without food.  1119 
Many aging researchers routinely fast their mice overnight prior to conducting an 1120 
insulin tolerance test. However, we believe that this is often unnecessary, and that a 1121 
short fast – long enough to ensure that all of the mice have not fed recently – is 1122 
usually sufficient to assess insulin tolerance, whilst being less stressful. Also, mice 1123 
fasted for 4-6 hours have a relatively high fasting blood glucose relative to mice 1124 
fasted overnight. This widens the dynamic range of the assay, increasing its power, 1125 
and also is safer, as it lessens the risk of hypoglycaemia. 1126 
CAUTION: C57BL/6J male mice over 30 months of age and C57BL/6J female mice 1127 
over 28 months of age should not be fasted overnight. We recommend ceasing 1128 
routine insulin tolerance tests after 24 months of age. 1129 
CRITICAL: The bedding should not be caloric; we recommend aspen bedding. The 1130 
use of commercial sterile water gels (e.g. hydrogel) instead of water bottles is 1131 
discouraged due to the small number of calories contained within the gel. 1132 
2. Move the mice to the procedure room for acclimatization at least one hour prior to the 1133 
start of the insulin tolerance assay. During this time period, you may continue to work 1134 
preparing the room and the mice (steps 3-5 below), but unnecessary noise should be 1135 
avoided. Weigh each mouse, marking the tail of each animal with a sharpie or similar 1136 
marker such that each animal can be readily distinguished from its cage mates 1137 
without picking it up. 1138 
 1139 
3. Prepared sterile diluted insulin for injection into the mice as described in “Reagents”. 1140 
CRITICAL: The insulin dose must be adjusted empirically for different strains and 1141 
conditions; for example, while we utilize 0.75U/kg for ad libitum fed C57BL/6J mice, 1142 
0.5U/kg is sufficient for CR mice fasted overnight. 1143 
CRITICAL: While this is an insulin tolerance test, at least 10 mL of sterile 30% 1144 
glucose should also be prepared and brought to the procedure room for the 1145 
emergency treatment of hypoglycaemic mice. 1146 
4. Calculate the volume of insulin in µL to be administered to each mouse.  1147 
We typically dilute 22.5 µL of stock insulin in 10mL of 0.9% sterile saline; using this 1148 
concentration, the volume of insulin to achieve a final dose of 0.75U/kg can be 1149 
rapidly calculated by dividing the body weight in grams by 30, and then multiplying by 1150 
100 (Example: (30 g mouse/30) x 100 = 100µL). Enter this value on the spreadsheet. 1151 
5. Prepare one syringe for each mouse, loading a single 1mL syringe with more than 1152 
the required volume of diluted insulin, and then removing all bubbles and extra 1153 
volume from the syringe.  1154 
6. To begin the insulin tolerance test, pick up the first mouse, and make a transverse 1155 
nick across the tail using the edge of a fresh razor blade.  1156 
7. Immediately collect a fresh drop of blood with a new glucometer test strip.  1157 
8. Gripping the mouse firmly, administer the insulin and start the timer, which will count 1158 
upwards from 0. Return the first mouse to its cage. 1159 
CRITICAL STEP: Insulin that was not correctly injected into the I.P. space will 1160 
aggregate and not enter the circulation; the experimenter should note any possibly 1161 
misinjected animals during this step. 1162 
9. Proceed to each mouse in sequence, nicking the tail, collecting a fresh drop of blood 1163 
with a glucometer test strip, and administering insulin as in steps 7-8. For each of 1164 
these subsequent mice, note the time of injection of insulin for each mouse on the 1165 
spreadsheet. 1166 
TROUBLESHOOTING:  1167 
Glucose levels should be determined in each mouse 15, 30, 45, 60, and 120 minutes 1168 
after glucose administration. Thus, when the timer reads “15:00”, it is time to take a 1169 
second reading from the first mouse that was injected. CRITICAL: It is important to 1170 
collect a fresh drop of blood that is not contaminated with blood from the previous 1171 
time point; this can be readily achieved by wiping the surface of the tail and then 1172 
gently stroking the tail until a fresh drop is released.  1173 
 1174 
CRITICAL: Continual assessment of the animal’s health is required throughout the 1175 
course of the assay in order to avoid hypoglycaemia. Mice with a blood glucose level 1176 
that rapidly drops below 20 mg/dL, that become cool to the touch, or that become 1177 
unresponsive should be removed from the assay, injected with approximately 1.5 1178 
g/kg sterile glucose, and placed in a new cage by themselves with food on the cage 1179 
bottom, and monitored until recovered. 1180 
CRITICAL STEP: If blood glucose levels do not fall in an animal following insulin 1181 
administration and misinjection is suspected as the cause, I.P. insulin can be 1182 
administered a second time immediately following the end of the ITT, and the blood 1183 
glucose tested 15 minutes later. If the animal now responds robustly, indicating the 1184 
first dose of insulin was likely misinjected, the ITT data for that animal should be 1185 
discarded. 1186 
10. At the end of the assay, ensure that bleeding has stopped in the mice. In rare cases, 1187 
use of a silver nitrate pencil or styptic powder may be necessary to stop the flow of 1188 
blood. Any mice that appear unresponsive or weak can be given 1g/kg glucose. 1189 
Return food to the cage.  1190 
CRITICAL: Place some food pellets on the bottom of the cage so animals can reach 1191 
easily.  1192 
 1193 
Grid hanging test to determine Muscle strength and neuromuscular function 1194 
CRITICAL The cage top test, also called grid hanging test or four limbs hanging test (as 1195 
opposed to the wire hanging test where only the forelimbs are used) is a quantitative, 1196 
inexpensive, non-invasive test used to measure the muscular strength and endurance of 1197 
mice in opposing the gravitational force with their four limbs. In fact, mice will endure to their 1198 
maximum strength to instinctively avoid falling. The advantage over the two limbs test is that 1199 
mice cannot prolong hanging time by balancing or using any other behaviour that may bias 1200 
the outcomes, so results tend to be more consistent and reliable 100. The test can be used to 1201 
measure decline in strength with age, if repeated measurement throughout life is conducted. 1202 
The ability to hang depends on sex, strain, and age 18,20. 1203 
1. Before starting the test, it is important to reduce to a minimum the stress of the 1204 
animal, so it is suggested to avoid changing cage bedding in the previous 24h.  1205 
2. Acclimate the mice for one hour to the testing room, and record the bodyweight of the 1206 
mouse. 1207 
3. Train the mice  before performing the test for the first time.  To do this…., CRITICAL 1208 
STEP In longitudinal studies, usually training the first time is enough. 1209 
4. Place the mouse on the grid, allow him to grip securely, then quickly turn the grid 1210 
upside down. The grid can be placed onto a holding apparatus or held by hand at a 1211 
fixed distance from the floor (80 cm) with a soft pad underneath to avoid injuries after 1212 
the fall. 1213 
CRITICAL: If the mice let go quickly because they lose their fear of falling, the 1214 
operator may hold the apparatus a bit higher.  1215 
5.  Start the timer when you invert the grid to record the latency time to fall (in seconds). 1216 
6. If the mouse falls before 10 seconds, allow it to repeat the test. If it still falls before 10 1217 
seconds on the third trial, record the best latency out of the three.  1218 
7. When finished, place the mouse back in the home cage, and test the next mouse. 1219 
Depending on how the apparatus is set up, it may be possible to test multiple mice at 1220 
once, especially for young ones that tend to hold on longer. It is not advisable to test 1221 
multiple old mice, as they tend to fall quickly and it is difficult to properly track all of 1222 
them. Also, ensure to wipe the grid and the underneath pad with 70% ethanol or 1223 
chlorine dioxide based sterilant (Clidox) before starting the next cage. 1224 
8. Repeat steps 4-7 until each mouse has done the test three times.  Allow the mice to 1225 
rest for 30 minutes in between. CRITICAL: In longitudinal studies, when the mice are 1226 
still relatively young it is advisable to consider the maximum hanging time (young 1227 
females can hang for more than 3 hours at 3-6 months) to have a more 1228 
discriminating power, whilst when comparing the effects of different treatments in 1229 
mice older than 12 months, usually setting a threshold at 7 minutes is sufficient. 1230 




Grip strength to determine Muscle strength and neuromuscular function 1235 
1. As general good practice acclimatize mice to the novel environment for 30-45 1236 
minutes prior to testing if the testing is carried out in a different room than their 1237 
normal housing. This test should be carried out on an open bench, as disruption from 1238 
the air flow in hoods can affect the results.  1239 
CRITICAL: For longitudinal studies, always perform the test at the same time of day. 1240 
Mice with missing or injured digits should not be tested. 1241 
2. Remove a mouse from the cage, gripping the base of the tail between the thumb and 1242 
the forefinger with the thumb below the forefinger. 1243 
3. Gently lower the mouse over the top of the grid so that only its front paws can grip 1244 
the grid. Stop when you can feel some pulling tension from the mouse 1245 
4. Keeping the torso horizontal, pull the mouse back steadily (not jerking) down the 1246 
complete length of the grid until the grip is released. Do not allow the rear paws to 1247 
touch the grid. If the rear paws do touch, then re-do the measurement. If the mouse 1248 
does not grip the grid properly then repeat the measurement. Similarly, if the mouse 1249 
turns backwards during the pull, or leaves the bar without resistance. 1250 
CRITICAL STEP: High variability in results can result from inconsistent performance 1251 
of the procedure by the operator. The operator may hold the mouse at an incorrect 1252 
angle, and the reading may be influenced by the forces generated by the operator 1253 
when pulling.  1254 
 1255 
5. Record the value from the meter. Repeat 3 times at 1-minute intervals and select the 1256 
highest value. Do not repeat the measurement more than 5 times. 1257 
6. Front paws alone are generally sufficient, but if time permits, grip strength 1258 
assessment can be repeated with all four paws on the grid. However, with old mice 1259 
the risk of fatigue is greater during multiple testing; allowing mice to rest at least 15 1260 
minutes before testing all four paws is recommended.  1261 
7. Normalize grip strength values by lean mass, or if lean mass is not available, use 1262 
body weight. Major differences in body weight can influence the results substantially, 1263 
potentially leading to erroneous conclusions. An alternative approach to analyze 1264 
these data is to use ANCOVA analysis using body weight or lean mass as a 1265 
covariate, which is widely accepted as a more statistically rigorous method to 1266 
address confounding factors such as body weight than simply normalizing to the 1267 
weight of the animals 101. As shown in Fig. 6A, the senolytic cocktail dasatinib plus 1268 
quercetin improves the grip strength of mice in this assay. 1269 
 1270 
Hanging bar to determine Muscle strength and neuromuscular function 1271 
1. Acclimate animals by placing them on the wire of the hanging bar apparatus for 1272 
several minutes watching that they don’t use their back legs or tail to climb on the 1273 
wire.  Sometimes, the mice are difficult to position such that they use only the front 1274 
limbs. This is a matter of patiently training the mice by gently repositioning it on the 1275 
wire in the correct way until they learn.  They may need to be repositioned several 1276 
times because they tend to use only their hind limbs.  1277 
CRITICAL: In longitudinal studies young mice that have not been previously tested 1278 
need to be trained and acclimated by placing on the wire each day for 5 days. Old 1279 
mice (24 months and older) usually are not so active, and do not jump on the wire or 1280 
run on it, and thus can be trained only once prior to testing. The outcome of  results 1281 
will depend on how well they are trained. 1282 
TROUBLESHOOTING:  1283 
CRITICAL STEP: if the mice let go quickly even when they are young, bring the wire 1284 
to a slightly higher position to induce a fear of falling. 1285 
2. On the day of the test, bring all mice to the procedure room 30 min prior to the test to 1286 
allow animals to acclimatize to local environmental cues. 1287 
3. Carefully take mouse at the base of its tail and bring it in proximity to the wire. 1288 
4. Let the mouse grasp the wire with the two forepaws only, and slowly lower the hind 1289 
limbs in such a way that the mouse hangs on the wire only supported by its 1290 
forepaws. 1291 
5. Start the timer as soon as the mouse is released. 1292 
6. When a mouse shows improper behaviour (like balancing on or deliberately jumping 1293 
off the wire, grabs the wire with four paws, or reaches the end of the wire) reposition 1294 
the mouse on the wire without stopping the timer. 1295 
7. If mouse falls before 10 seconds have elapsed, remember what time they fell and 1296 
quickly repeat the test. If on the 3rd try the mouse still falls before 10 seconds, record 1297 
the best latency out of 3 attempts.   1298 
8. When a mouse falls off the wire, stop the timer and record the hanging time. When 1299 
mice are able to hang for 5mins take them off the wire and return them to the cage. 1300 
9. Record hanging time.  1301 
10. Once one trial is completed for all the mice, complete a second trial  by repeating 1302 
steps 3-9. There should be approximately  30 minutes break between trials for each 1303 
mouse. Repeat steps 3-9 again so each mouse has done a total of 3 trials. 1304 
11.  Take the best time out of the 3 trials for analysis and normalize results to lean mass 1305 
or body weight, or perform ANCOVA using weight or lean mass as covariant. As 1306 
shown in Fig. 6B, the senolytic cocktail dasatinib plus quercetin improves the hang 1307 
time of mice in this assay. In young mice and mice up to 18 month old, test every 6 1308 
months. After that, we recommend testing mice monthly. 1309 
 1310 
Rotarod to determine Muscle strength and neuromuscular function 1311 
1. CRITICAL Training mice prior to conducting the rotarod assay is essential. An 1312 
example training schedule is in steps 1 and 2. Place mice on the rotarod at a 1313 
constant speed of 4rpm for a minimum of 60s; and up to 300s. If they fall place them 1314 
back on. Use a timer to count the 60-300s. 1315 
2. On the next two dates (Days 2 and 3), train the mice again by placing them on the 1316 




CAUTION: As it is the case for behavioural experiments, it is important to not make 1321 
the mice anxious, and thus careful handing is recommended. 1322 
CRITICAL STEP If mice have been previously tested (as in a longitudinal study), 1323 
perform a refresher training run of the mice as above on just the day before testing. 1324 
Do not train mice on the day of the test in order to avoid fatigue. If the mice fall then 1325 
place them back on. Nothing needs to be recorded during this refresher. 1326 
 1327 
3. The day after the last day of training bring the mice into the testing room, allowing 1328 
them to acclimatise to the room for 30 minutes. During this time, weigh all of the 1329 
mice, marking tails if desired for easier animal identification. 1330 
4. Whilst the mice are acclimatising, clean the Rotarod apparatus in accordance with 1331 
facility protocols and manufacturer’s instructions.  1332 
5. Put some padding at the bottom to ensure mice are not harmed during the fall. Some 1333 
of us fill a Ziplock bag with clean aspen bedding; this has the advantage of being 1334 
sanitizable.  1335 
6. Start the rotarod at 4 rpm, and quickly place each mouse in a separate lane of the 1336 
rotarod; mice should be placed facing away from the experimenter. The maximum 1337 
number of mice that can be analysed at a single time is determined by the number of 1338 
lanes on the equipment, but is typically four-five.  1339 
7. Once all the mice have settled and are facing away from the investigator, accelerate 1340 
the rotarod. The acceleration speed and interval can be determined by the 1341 
investigator; but accelerating from 4 to 40 rpm in 300 sec is typical.  1342 
8. The timers for all five lanes will start counting up. If the mouse falls within 10 second 1343 
from the start put it back on. If it fails three times to remain on the Rotarod as it slowly 1344 
rotates, remove them from the trial and record the time as 0s. 1345 
CRITICAL: if a mouse has not fallen by the end of the 300s, the experiment should 1346 
be ended and the time recorded as 300 seconds. This maximum time may need to 1347 
be adjusted in different strains to fully capture the dynamic range of the animals’ 1348 
abilities. 1349 
CRITICAL: When the mouse falls, it will usually (but not always) stop the timer. While 1350 
recording with the computer is a useful timesaver, a paper record should also be kept 1351 
such that data can be rapidly captured if the time fails to stop.   1352 
9. As soon as a mouse falls, carefully remove the mouse from the apparatus and return 1353 
the mice to the home cage. In the case of passive rotation (the mice hang the rotarod 1354 
and complete a rotation), reposition the mice once; if this behaviour is repeated, 1355 
consider this as the time to fall (but make a note). 1356 
10. Repeat the test (steps 6-9) so each mouse does it 3 times.     CRITICAL: Trials of the 1357 
same animal should be separated by a minimum of 15 minutes. If comparisons 1358 
between cohorts analysed on separate days are desired, the resting time should be 1359 
similar between each cohort. 1360 
11. Plot rotarod performance as time to fall, or  as maximal speed. A major 1361 
consideration is that lighter animals, if healthy, typically can stay on the 1362 
rotarod longer than obese animals simply due to body weight. Rotarod data 1363 
can be normalized to body weight, although the most rigorous analysis is to 1364 
perform a 2-way ANCOVA with body weight or lean mass as a covariant. As 1365 
shown in Fig. 6C, the senolytic cocktail dasatinib plus quercetin improves the 1366 





Timing varies  each assay in the toolbox, and for most assays in the toolbox timing will 1372 
increase as the number of animals increase. We have given indicative times for each test for 1373 
n=10 mice and two operators in table 1. Table 1 also provides a schedule of when to carry 1374 




We have selected these tests for their relative simplicity. Therefore it is unlikely that they do 1379 
not work. However, variability may be high and differences may not be detected. To address 1380 
this we have highlighted all the critical steps in each protocol. If any problem is encountered 1381 
we recommend to carefully re-examine those steps. 1382 
Table 2 also gives guidance regarding some of the most commonly encountered problems. 1383 
 1384 
ANTICIPATED RESULTS  1385 
Cardiac function 1386 
Generally speaking, mice are remarkably resistant to chronic left ventricular pressure 1387 
overload and have relatively preserved systolic function (but a reasonable hypertrophic 1388 
response) during all but the most severe insults (e.g., transverse aortic constriction).  As a 1389 
general guideline, we exclude animals that have evidence of significant aortic or mitral valve 1390 
regurgitation (which is almost always associated with a phenotype of cardiac hypertrophy 1391 
and dilatation) unless that is a specific aim of the study.  Importantly, measures of cardiac 1392 
mass (either echocardiographic estimates or direct wet weights after euthanasia) should be 1393 
evaluated as both absolute weights and when normalized by bodyweight.   1394 
In our experience, severe systolic cardiac dysfunction is an uncommon phenotype with 1395 
unstressed chronological aging (i.e., ejection fraction is generally well-preserved and greater 1396 
than 75% in most strains).  One may observe subtle reductions in ejection fraction, however, 1397 
which are generally associated with increases in end-diastolic operating volumes and larger 1398 
increases in end-systolic volumes and slight increases in ventricular thickness/mass. 1399 
Diastolic dysfunction can be observed with aging in mice, with cardiac hypertrophy and 1400 
decreased myocardial performance observed during aging47, and significant changes in the 1401 
E/e’ ratio can become evident with long-term pathophysiological stressors.  As is the case 1402 
with numerous patient populations, increases in the E/e’ ratio are indicative of diastolic 1403 
dysfunction.  While our experience to date would suggest that E/e’ values ranging from 15-1404 
25 are typical in young, unstressed animals, there can be significant variability across 1405 
strains.  With prolonged stressors combined with chronological aging, we have observed 1406 
values of E/e’ that exceed 75 units, and can be associated with increases in ventricular wall 1407 
thickness and overall mass.   1408 
Collectively, these approaches are readily applicable to assessment of cardiac 1409 
function with aging in small animals/rodents.  The procedure described in this toolbox 1410 
provides  a simply way to assess cardiovascular function longitudinally in aging mice. While 1411 
inbred mouse strains are quite resistant to the development of atherosclerosis102, mice can 1412 
and do develop both systolic and diastolic cardiac dysfunction with age103. We expect that 1413 
many geroprotectors will prevent or reverse pre-existing age-dependent cardiac hypertrophy 1414 
and diastolic dysfunction35,47,48. This can be seen by an improvement in left ventricular 1415 
ejection fraction, improved systolic function (LVIDd) or decreased LVIDs. 1416 
Further comprehensive assessments of cardiac and heart valve function (as described 1417 
previously by Verzosa and colleagues89) generally require significant training and 1418 
experience, and should not be attempted without extensive training to ensure appropriate 1419 
technique and rigorous/reproducible results.   1420 
 1421 
Cognitive function 1422 
 The tracking software can output a range of parameters, such as velocity, time spent 1423 
exploring both objects (novel and known) and time not exploring objects. Tracking software 1424 
including nose-point detection is more reliable than tracking tools based only on the 1425 
detection of the center point of the animal23. We consider a behaviour as active object 1426 
exploration if the nose point of the mouse is within the pre-defined target zone with a 1427 
distance to the object equal to or less than 2 cm81. Climbing on the objects itself is not 1428 
considered object exploration unless it is combined with sniffing the object82. When 1429 
automatically scoring object exploration, climbing behaviours can be excluded by removing 1430 
data in which the center point of the mouse is located within the target zone23. Despite the 1431 
use of automated systems, it is recommended that an experienced researcher review the 1432 
output of the software to detect potential misbehaviour of the animals during the test, which 1433 
cannot be distinguished by the tracking software. 1434 
 1435 
Results should be presented as a Discrimination Index (DI).  The DI is the difference 1436 
between the time exploring the novel and the familiar object, divided by the total amount of 1437 
exploration of both objects. Exploration is defined as directing the nose to the object at a 1438 
maximum distance of one centimetre. Some animals may explore very few times, or not 1439 
explore one of the objects during any of the training or the test phases. Those animals are 1440 
excluded from the analysis. A positive score means more time spent exploring the novel 1441 
object and a negative score indicates more time spent exploring the familiar object. A score 1442 
of 0 indicates no preference for any of the objects. However, a minimum DI threshold of 1443 
+0.20 was agreed to indicate meaningful novel object discrimination. It is expected that the 1444 
vast majority of animals will explore the novel object for longer than the known object. An 1445 
example of data is presented in Fig.3. 1446 
Geroprotectors such as rapamycin have shown to improve cognitive function with age. 1447 
Particularly in the context of mouse models of Alzheimer’s disease, there is growing 1448 
evidence that geroprotectors may be able to treat or prevent the disease and its associated 1449 
cognitive deficits52,53,104-107. We expect that young mice will spend more time exploring new 1450 
objects as opposed to already known objects. This effect is lost as the mouse ages, and old 1451 
mice, which will spend equal time with old and new objects. An improvement in this function 1452 
would be shown by the recovery of this ability to explore new objects for longer.  1453 
  1454 
Body Composition assay of metabolic health 1455 
 The procedure described in this toolbox is a simple way to measure body 1456 
composition using magnetic resonance imaging (MRI). Many longevity-promoting 1457 
interventions are associated with reduced adiposity, including diets in which total calories, 1458 
protein, or methionine are restricted12,17,18,108-111. Some pharmaceutical interventions which 1459 
extend lifespan, including rapamycin112 and acarbose113, are likewise associated with 1460 
reduced adiposity. On the other hand, senescence cell clearance restores adipose tissue 1461 
function and prevents fat loss in aged mice28. A geroprotector would likely help to preserve 1462 
and maintain both muscle mass and adipose tissue function, and limit increases in ectopic 1463 
lipid accumulation during aging.  1464 
Energy Balance to assay metabolic health 1465 
In this toolbox, we describe a simple procedure for the measurement of energy balance – 1466 
simultaneous evaluation of food consumption, activity, and energy expenditure as assessed 1467 
by indirect calorimetry using an open flow respirometry system. Very precise CO2 and O2 1468 
sensors measure the difference in CO2 and O2 concentrations in air volumes flowing through 1469 
control or animal cages. The amount of oxygen consumed, and the amount of CO2 1470 
produced, over a given period of time can thus be determined.  1471 
Specific measurements of interest obtained from the energy balance assay usually include 1472 
the VCO2 and VO2, the Respiratory Exchange Ratio (RER), activity, food consumption, and 1473 
energy expenditure (heat). While differences between groups can be measured at multiple 1474 
time points, typically averages during the course of the light and dark cycles are calculated 1475 
and compared between groups. As shown in Fig. 4, RER, food consumption, and energy 1476 
expenditure are higher at night, as expected since mice are nocturnal, and these values are 1477 
affected by dietary composition.  There are specific issues for each type of data: 1478 
• Activity: The Oxymax software for the Columbus Instrument CLAMS system 1479 
distinguishes between all activity and ambulatory activity; reporting the sum of 1480 
ambulatory along the X and Y axis may provide the most accurate assessment of 1481 
activity.  1482 
• Energy expenditure: may be normalized to either body weight or lean mass. While 1483 
many investigators believe normalizing to lean mass is best, this may be 1484 
inappropriate as it assumes that fat mass has a minimal contribution to metabolism98. 1485 
Analysing both group and body composition effects using analysis of covariance is 1486 
widely considered to be the gold-standard 98.  1487 
• Food consupmtion: It is very important to inspect the food consumption data and 1488 
remove any data that reports food consumption of less than zero, as this indicates 1489 
either a scale problem or the mouse “playing” with food. 1490 
 1491 
We expect that the value of the RER will vary between approximately 0.7, which 1492 
reflects the exclusive utilization of fats, and 1.0, which reflects the exclusive utilization of 1493 
carbohydrates 3,6,18,114. In actual fact, the measured RER can temporarily exceed 1.0 in 1494 
animals as well as humans that are exercising very vigorously or are calorie restricted.  1495 
While the effect of geroprotectors on RER and other readout may vary, healthy 1496 
young animals have increased “metabolic flexibility” – the ability to adapt and respond to 1497 
changes in metabolic demand115 – including the switch between fasting and fed states in 1498 
response to the day-night cycle. Unhealthy conditions, including aging and metabolic 1499 
disease, impairs metabolic flexibility and the ability of RER to rapidly switch as mice cycle 1500 
between the dark and light portions of the day. We expect that young and healthier animals 1501 
– including aged mice treated with effective geroprotectors – will exhibit better metabolic 1502 
flexibility, and thus a greater difference in RER measured during the dark and light portions 1503 
of the day.  1504 
Glucose tolerance test as an assay of metabolic health 1505 
    1506 
The protocol in this toolbox is an effective way to determine glucose tolerance, which when 1507 
performed after an overnight fast provides insight into hepatic gluconeogenesis and insulin 1508 
sensitivity, as well as pancreatic beta cell function. It is expected that glucose will be cleared 1509 
more rapidly, and hepatic glucose production suppressed more rapidly, if a geroprotector is 1510 
effective. Calorie restriction, as well as many other geroprotective interventions including 1511 
protein restriction, metformin, and acarbose improve glucose tolerance in both young and 1512 
aged mice, reducing fasting blood glucose levels and decreasing area under the 1513 
curve3,12,14,17,18,60,62,116. If important for the analysis, groups of mice can be compared at 1514 
individual time points using two-way repeated measures ANOVA. However, it is usually 1515 
more biologically meaningful (https://www.graphpad.com/support/faq/when-does-it-make-1516 
sense-to-use-repeated-measures-two-way-anova/), as well as more powerful, to calculate 1517 
area under the curve (AUC) and use AUC as the basis for the statistical analysis. As shown 1518 
in Fig. 5A, the geroprotector rapamycin impairs glucose tolerance – increasing the AUC – 1519 
when injected daily, but when dosed intermittently has no significant effect on glucose 1520 
tolerance. 1521 
Insulin tolerance test as an assay of metabolic health 1522 
The protocol in this toolbox is an effective way to determine insulin sensitivity, which is often 1523 
– although not always – increased in interventions that promote metabolic health. As with 1524 
glucose tolerance, calorie restriction and a number of other geroprotective diets and 1525 
interventions in mammals are strongly associated with improved insulin sensitivity 1526 
3,12,17,61,111,113. Glucose data for each animal should be normalized to its fasting (basal) blood 1527 
glucose level (fasting blood glucose = 100% of basal glucose), and plotted as % of basal 1528 
blood glucose. As with glucose tolerance tests, groups of mice can be compared at 1529 
individual time points using two-way repeated measures ANOVA. However, it is usually 1530 
better to calculate the area under the curve (AUC) of the normalized blood glucose values, 1531 
and use AUC as the basis for the statistical analysis. As shown in Fig. 5B, intermittent 1532 
administration of the geroprotector rapamycin does not impair insulin sensitivity; this is in 1533 
contrast to daily administration, which does impair insulin sensitivity and increases the AUC 1534 
15. 1535 
 1536 
Muscle strength and neuromuscular function 1537 
Assessment of muscle and neuromuscular function can be challenging as 1538 
measurement of these phenotypes may be influenced heavily by the operator, or by how 1539 
cooperative the individual animal is. In addition severe muscle defects occur at 28-30 1540 
months in C57BL6/J mice117,118. For this reason improvements are small and difficult to 1541 
detect. It is advisable that muscle function is tested using multiple measures of outcome to 1542 
overcome these issues. 1543 
 1544 
Grid hanging test and Grip strength. Grip strength is “a universal measurement 1545 
used to assess physical competency in older adults” humans119, and the decline in grip 1546 
strength with age is predictive for both the risk of inability to perform activities of daily living, 1547 
an important component of healthspan, and mortality in humans120. For this reason it is used 1548 
in mice4,12. Grip strength as measured using a grip strength meter may decline with age in 1549 
mice, but this has not been observed by every group119,121. Interventions which benefit the 1550 
muscle system should result in an increase in grip strength, and this has been observed by 1551 
some groups29,122. However, this is not always the case.  1552 
We believe the variability associated with this assay, and the small size of the effect 1553 
means that most studies are underpowered. We have observed that minor variations can 1554 
confound the results, and that different operators even within the same lab can see different 1555 
results.  We have tried to describe the procedure in detail. However, for grip strength it is 1556 
advisable that new operators are trained by someone experienced. 1557 
The grid hanging test, also known as the cage top test, four limbs hanging test, grid 1558 
wire hang, or inverted cling test, is a widely used and easy to perform assay; grip strength as 1559 
measured by this assay also declines with age in mice18,123,124, and we expect it to increase 1560 
as a result of an geroprotective intervention. This can be a more robust assay than grip 1561 
strength.  1562 
 1563 
Hanging bar. This test seeks to evaluate motor function measuring forelimb muscle 1564 
strength of the mouse. It is expressed as latency to fall from the wire. Neuromuscular 1565 
abnormalities in mice can be detected as well with this test18,125. We expect that 1566 
geroprotective interventions will often increase wire hang time in aged mice18,19. 1567 
 1568 
Rotarod The rotarod assay is one of the most commonly used tests in the study of 1569 
aging mouse healthspan. It is measured as the latency (time) to fall. This time declines with 1570 
age, and neuromuscular abnormalities in mice can be detected as well with this test 44,125,126. 1571 
Rotarod running time is positively impacted by interventions including calorie restriction34, 1572 
metformin3, nicotinamide20, and rapamycin127, and it is expected that the latency time to fall 1573 
is increased with the use of geroprotectors19,122. 1574 
 1575 
TABLE 2:  TROUBLESHOOTING 1576 
Cardiac function 1577 
Step Problem Possible reason Possible Solution 
5 No heart rate/ECG 
signal 
Poor contact with 
platform, lack of 
signal conduction 
Check foot placement 
and use 
electroconductive gel 
if needed, check 
connections of 
platform to system 





gel for contact 






11 Excess LV 
dilation/poor systolic 








placing the animal on 
the platform, inducing 
under the lowest level 
of isoflurane possible, 
and rapidly lowering 
to a minimal plane of 
anesthesia.  Avoid 
use of anesthesia 




All steps Significant 
bradycardia 





pressure on chest 
Lower anesthesia 
concentration; ensure 
negligible pressure is 
applied to the chest 
while imaging 




Adverse response to 
anesthesia  
Remove animal from 
nose cone and allow 
to recover fully.  
Attempt imaging 
again after full 
recovery or on 
another day.  
 1578 
Cognitive function 1579 
Step Problem Possible reason Possible Solution 
5 Some animals might 
spend most of the time 
in a corner, immobile 
and without exploring 
Stress Special care in the 
behaviour room 
environment. If it 
happens in individual 
animals only, these 
should be removed 
from the experiment. 
If this is seen in 
many animals, it may 
be necessary to 
identify and eliminate 
stressor present in 
the behavioural 
testing or animal 
housing 
environment. Stress 
related to the 
experimental 
procedure can also 




5 Some objects promote 
animals to play with the 
object including 
climbing on top of the 
object and remaining 
there for a while 
This is most often due 
to mobile pieces in 
the object or a big 
surface on top of the 
object 
Pre-select a different 
pair of objects 
6 Lack of increased 
exploration time of 
novel vs. familiar object 
Stress  
 
Insufficient training  
 




stressors in the 
behavioural testing 







Pre-select a different 
pair of objects 
 1580 
Metabolic Health 1581 
Body Composition 1582 
Step Problem Possible reason Possible Solution 
2 Machine unable to 
calibrate, takes an 
unusually long time to 
calibrate, or takes an 
unusually long time to 
read a single animal. 
Too much metal 
mass within a 6-foot 
radius of the MRI.  
Increase separation 
between metal 
objects and the MRI. 
5 Sum of the fat mass, 
lean mass, and water 
weight differ by more 
than 5% from the 
weight as assessed 
using a scale. 
Too much metal 
mass within a 6-foot 
radius of the MRI; 
alternatively, 
calibration standard 
may have leaked. 
Increase separation 
between metal 







Energy Balance 1584 
Step Problem Possible reason Possible Solution 
5 RER results are non-
physiological 
If the reference cage 
is only read at the 
Set the system to 
read the reference 
(continuously > 1.0 or 
< 0.7) and O2/CO2 in 
readings are 
constant. 
beginning of each 
experimental run, but 
room air O2/CO2 
concentrations 
change, the delta O2 
and delta CO2 will be 
calculated incorrectly. 
cage (and update O2 
in and CO2 values) 
every time it cycles 
through the 
experimental 
chambers.  once 
before each reading  
5 RER results are non-
physiological 
(continuously > 1.0 or 
< 0.7) 
Valves on one or 
more of the 
calibration air tanks 
may have been shut 
during the calibration 
procedure; 
alternatively, the 
calibration air may 
have settled or the 
tank may be empty.  
Recalibrate system, 
checking that there is 
adequate gas flow 
from the calibration 
tanks.  
5 The gas values read 
from all of the 
chambers (O2 
out/CO2 out) 
becomes “stuck” on 
the same value  
A bubble may have 




Data analysis Food consumption 
values are negative 
or absurdly high. 
Mice may have 
greater than intended 
access to the feeder, 
and either deposit 
waste products or 
remove food without 
eating it; or the scale 
may be defective. 
Discard data from 
cages with negative 
food consumption 
values, and inspect 
the cage bottom to 
determine if food was 
removed from the 
feeder and not 
consumed. The cage 
floor may be able to 
be reset to limit the 
access of small/lean 
mice. Verify that the 





Glucose tolerance test 1586 
Step Problem Possible reason Possible Solution 
8 Blood glucose 
reading seems 
extraordinarily high or 
low based on reading 
at prior time point.  
Approximately 2% of 
reads are unusual, 
due to causes that 
include defective or 
contaminated 
glucose  test strips or 
Wipe the tail, and 
with a fresh drop of 
blood immediately 
repeat the reading 
with a fresh test strip. 
If value differs by 
samples, or samples 
that are too small or 
partially clotted. 
more than 10% from 
the first reading, use 
the data from this 
second reading; 
otherwise, keep the 
first reading. 
8 Blood glucose 
monitor says all or 
most glucose test 
strips are defective. 
Monitor failure. Replace blood 
glucose monitor. As 
many monitors are 
inexpensive, spares 
can often be kept on 
hand. 
 1587 
Insulin tolerance test 1588 
Step Problem Possible reason Possible Solution 
9 Blood glucose 
reading seems 
extraordinarily high or 
low based on reading 
at prior time point.  
Approximately 2% of 
reads are unusual, 
due to causes that 
include defective or 
contaminated 
glucose  test strips or 
samples, or samples 
that are too small or 
partially clotted. 
Wipe the tail, and 
with a fresh drop of 
blood repeat the 
reading with a fresh 
test strip. If value 
differs by more than 
10% from the first 
reading, use the data 
from this second 
reading; otherwise, 
keep the first reading. 
9 Blood glucose 
monitor says all or 
most glucose test 
strips are defective. 
Monitor failure. Replace blood 
glucose monitor. As 
many monitors are 
inexpensive, spares 
can often be kept on 
hand. 
8 and 10 Blood glucose level 
does not drop or rises 
following insulin 
administration. 
Insulin that is not 
correctly injected into 
the I.P. space will 
aggregate and not 
enter the circulation. 
If misinjection is 
suspected, I.P. 




the end of the ITT, 
and the blood 
glucose tested 15 
minutes later. If the 
animal now responds 
robustly, the ITT data 
for that animal should 
be discarded as a 
result of misinjection. 
 1589 
Muscle strength and neuromuscular function 1590 
Grid hanging test  1591 
Step Problem Possible reason Possible Solution 
4 Mice let go very 
quickly 
Grid not high 
enough/loss of fear of 
falling 
Place the grid slightly 
higher 
 1592 
Grip strength 1593 
Step Problem Possible reason Possible Solution 
6 Very variable 
readings 
Operator holding the 
mouse at an angle 
Ensure the mouse is 
kept horizontally 
when pulling and the 
force applied is 
proportionate 
6 Very variable 
readings 
Claws are too long Claw length may be 
affected by activity or 
environment (e.g. 
bedding). Change 
bedding or clip claws 
 1594 
 1595 
Hanging bar 1596 
Step Problem Possible reason Possible Solution 
1 Mouse is difficult to 
position  
Insufficient training Gently reposition the 
mouse until they 
have learnt 
1 Mouse let go quickly 
even if they are 
young 
They have lost fear of 
falling 




Step Problem Possible reason Possible Solution 
7 Mouse change 
position on the 
rotarod, 
Insufficient training Gently reposition the 
mouse. 
7 Mice fall from the 
rotarod too quickly. 
Old, frail mice, 
background noise. 
Gently position mouse 
on the track again. 
Reduce exposure to 
possible distractions. 
Remove extremely 
frail mice from the 
assay.   
7 Mouse turns around 
in the middle of the 
experiment and start 
walking in the 
opposite direction 
Insufficient training Gently reposition the 
mouse until they have 
learnt 
7 Mouse “hugs” the rod 
and starting looping 
Insufficient training Gently reposition the 











 A lack of standardized techniques to assess healthspan in mice has resulted in 1608 
reduced reproducibility of results and slowed progress in developing geroprotective agents 1609 
to extend healthy life. The toolbox described here describes a comprehensive set of 1610 
techniques that can be used to consistently and reproducibly assess the healthspan of mice. 1611 
We expect that the use of this toolbox will permit investigators to rapidly and robustly identify 1612 
candidate geroprotectors that may potentially be of clinical use in the treatment of many age-1613 
related diseases in humans.  1614 
 1615 
References 1616 
1 Bellantuono, I. Find drugs that delay many diseases of old age. Nature 554, 293-295, 1617 
doi:10.1038/d41586-018-01668-0 (2018). 1618 
2 Tchkonia, T. & Kirkland, J. L. Aging, Cell Senescence, and Chronic Disease: Emerging 1619 
Therapeutic Strategies. JAMA 320, 1319-1320, doi:10.1001/jama.2018.12440 (2018). 1620 
3 Martin-Montalvo, A. et al. Metformin improves healthspan and lifespan in mice. Nature 1621 
communications 4, 2192, doi:10.1038/ncomms3192 (2013). 1622 
4 Neff, F. et al. Rapamycin extends murine lifespan but has limited effects on aging. J Clin 1623 
Invest 123, 3272-3291, doi:10.1172/JCI67674 (2013). 1624 
5 Zhu, Y. et al. The Achilles' heel of senescent cells: from transcriptome to senolytic drugs. 1625 
Aging Cell 14, 644-658, doi:10.1111/acel.12344 (2015). 1626 
6 Arriola Apelo, S. I., Pumper, C. P., Baar, E. L., Cummings, N. E. & Lamming, D. W. Intermittent 1627 
Administration of Rapamycin Extends the Life Span of Female C57BL/6J Mice. J Gerontol A 1628 
Biol Sci Med Sci 71, 876-881, doi:10.1093/gerona/glw064 (2016). 1629 
7 Richardson, A. et al. Measures of Healthspan as Indices of Aging in Mice-A Recommendation. 1630 
J Gerontol A Biol Sci Med Sci 71, 427-430, doi:10.1093/gerona/glv080 (2016). 1631 
8 Hamm, R. J., Pike, B. R., O'Dell, D. M., Lyeth, B. G. & Jenkins, L. W. The rotarod test: an 1632 
evaluation of its effectiveness in assessing motor deficits following traumatic brain injury. J 1633 
Neurotrauma 11, 187-196, doi:10.1089/neu.1994.11.187 (1994). 1634 
9 Wolff, B. S., Raheem, S. A. & Saligan, L. N. Comparing passive measures of fatigue-like 1635 
behavior in mice. Scientific reports 8, 14238, doi:10.1038/s41598-018-32654-1 (2018). 1636 
10 Schafer, M. J. et al. Exercise Prevents Diet-Induced Cellular Senescence in Adipose Tissue. 1637 
Diabetes 65, 1606-1615, doi:10.2337/db15-0291 (2016). 1638 
11 Halldorsdottir, S., Carmody, J., Boozer, C. N., Leduc, C. A. & Leibel, R. L. Reproducibility and 1639 
accuracy of body composition assessments in mice by dual energy x-ray absorptiometry and 1640 
time domain nuclear magnetic resonance. Int J Body Compos Res 7, 147-154 (2009). 1641 
12 Potter, P. K. et al. Novel gene function revealed by mouse mutagenesis screens for models of 1642 
age-related disease. Nature communications 7, 12444, doi:10.1038/ncomms12444 (2016). 1643 
13 Xie, K. et al. Epigenetic alterations in longevity regulators, reduced life span, and 1644 
exacerbated aging-related pathology in old father offspring mice. Proc Natl Acad Sci U S A 1645 
115, E2348-E2357, doi:10.1073/pnas.1707337115 (2018). 1646 
14 Lamming, D. W. et al. Young and old genetically heterogeneous HET3 mice on a rapamycin 1647 
diet are glucose intolerant but insulin sensitive. Aging Cell 12, 712-718, 1648 
doi:10.1111/acel.12097 (2013). 1649 
15 Lamming, D. W. et al. Rapamycin-induced insulin resistance is mediated by mTORC2 loss and 1650 
uncoupled from longevity. Science 335, 1638-1643, doi:10.1126/science.1215135 (2012). 1651 
16 Arriola Apelo, S. I. et al. Alternative rapamycin treatment regimens mitigate the impact of 1652 
rapamycin on glucose homeostasis and the immune system. Aging Cell 15, 28-38, 1653 
doi:10.1111/acel.12405 (2016). 1654 
17 Stout, M. B. et al. 17alpha-Estradiol Alleviates Age-related Metabolic and Inflammatory 1655 
Dysfunction in Male Mice Without Inducing Feminization. J Gerontol A Biol Sci Med Sci 72, 3-1656 
15, doi:10.1093/gerona/glv309 (2017). 1657 
18 Alfaras, I. et al. Health benefits of late-onset metformin treatment every other week in mice. 1658 
NPJ Aging Mech Dis 3, 16, doi:10.1038/s41514-017-0018-7 (2017). 1659 
19 Diaz-Ruiz, A. et al. Overexpression of CYB5R3 and NQO1, two NAD(+) -producing enzymes, 1660 
mimics aspects of caloric restriction. Aging Cell, e12767, doi:10.1111/acel.12767 (2018). 1661 
20 Mitchell, S. J. et al. Nicotinamide Improves Aspects of Healthspan, but Not Lifespan, in Mice. 1662 
Cell Metab 27, 667-676 e664, doi:10.1016/j.cmet.2018.02.001 (2018). 1663 
21 Allard, J. S. et al. Prolonged metformin treatment leads to reduced transcription of Nrf2 and 1664 
neurotrophic factors without cognitive impairment in older C57BL/6J mice. Behav Brain Res 1665 
301, 1-9, doi:10.1016/j.bbr.2015.12.012 (2016). 1666 
22 Lee, S. et al. Assessment of Cognitive Impairment in a Mouse Model of High-Fat Diet-Induced 1667 
Metabolic Stress with Touchscreen-Based Automated Battery System. Exp Neurobiol 27, 1668 
277-286, doi:10.5607/en.2018.27.4.277 (2018). 1669 
23 Benice, T. S. & Raber, J. Object recognition analysis in mice using nose-point digital video 1670 
tracking. J Neurosci Methods 168, 422-430, doi:10.1016/j.jneumeth.2007.11.002 (2008). 1671 
24 Whitehead, J. C. et al. A clinical frailty index in aging mice: comparisons with frailty index 1672 
data in humans. J Gerontol A Biol Sci Med Sci 69, 621-632, doi:10.1093/gerona/glt136 1673 
(2014). 1674 
25 Feridooni, H. A., Sun, M. H., Rockwood, K. & Howlett, S. E. Reliability of a Frailty Index Based 1675 
on the Clinical Assessment of Health Deficits in Male C57BL/6J Mice. J Gerontol A Biol Sci 1676 
Med Sci 70, 686-693, doi:10.1093/gerona/glu161 (2015). 1677 
26 Kane, A. E., Keller, K. M., Heinze-Milne, S., Grandy, S. A. & Howlett, S. E. A Murine Frailty 1678 
Index Based on Clinical and Laboratory Measurements: Links Between Frailty and Pro-1679 
inflammatory Cytokines Differ in a Sex-Specific Manner. J Gerontol A Biol Sci Med Sci 74, 1680 
275-282, doi:10.1093/gerona/gly117 (2019). 1681 
27 Sukoff Rizzo, S. J. et al. Assessing Healthspan and Lifespan Measures in Aging Mice: 1682 
Optimization of Testing Protocols, Replicability, and Rater Reliability. Curr Protoc Mouse Biol 1683 
8, e45, doi:10.1002/cpmo.45 (2018). 1684 
28 Palmer, A. K. et al. Targeting senescent cells alleviates obesity-induced metabolic 1685 
dysfunction. Aging Cell, e12950, doi:10.1111/acel.12950 (2019). 1686 
29 Xu, M. et al. Senolytics improve physical function and increase lifespan in old age. Nat Med 1687 
24, 1246-1256, doi:10.1038/s41591-018-0092-9 (2018). 1688 
30 Mitchell, S. J. et al. Effects of Sex, Strain, and Energy Intake on Hallmarks of Aging in Mice. 1689 
Cell Metab 23, 1093-1112, doi:10.1016/j.cmet.2016.05.027 (2016). 1690 
31 Cummings, N. E. et al. Restoration of metabolic health by decreased consumption of 1691 
branched-chain amino acids. The Journal of physiology 596, 623-645, doi:10.1113/JP275075 1692 
(2018). 1693 
32 Xie, K. et al. Every-other-day feeding extends lifespan but fails to delay many symptoms of 1694 
aging in mice. Nature communications 8, 155, doi:10.1038/s41467-017-00178-3 (2017). 1695 
33 McGreevy, K. R. et al. Intergenerational transmission of the positive effects of physical 1696 
exercise on brain and cognition. Proc Natl Acad Sci U S A, doi:10.1073/pnas.1816781116 1697 
(2019). 1698 
34 Lamming, D. W. et al. Depletion of Rictor, an essential protein component of mTORC2, 1699 
decreases male lifespan. Aging Cell 13, 911-917, doi:10.1111/acel.12256 (2014). 1700 
35 Zhu, Y. et al. New agents that target senescent cells: the flavone, fisetin, and the BCL-XL 1701 
inhibitors, A1331852 and A1155463. Aging (Albany NY) 9, 955-963, 1702 
doi:10.18632/aging.101202 (2017). 1703 
36 Yousefzadeh, M. J. et al. Fisetin is a senotherapeutic that extends health and lifespan. 1704 
EBioMedicine 36, 18-28, doi:10.1016/j.ebiom.2018.09.015 (2018). 1705 
37 Xu, M. et al. Targeting senescent cells enhances adipogenesis and metabolic function in old 1706 
age. eLife 4, e12997, doi:10.7554/eLife.12997 (2015). 1707 
38 Mercken, E. M. et al. SRT2104 extends survival of male mice on a standard diet and 1708 
preserves bone and muscle mass. Aging Cell 13, 787-796, doi:10.1111/acel.12220 (2014). 1709 
39 Mitchell, S. J. et al. The SIRT1 activator SRT1720 extends lifespan and improves health of 1710 
mice fed a standard diet. Cell reports 6, 836-843, doi:10.1016/j.celrep.2014.01.031 (2014). 1711 
40 Minor, R. K. et al. SRT1720 improves survival and healthspan of obese mice. Scientific reports 1712 
1, 70, doi:10.1038/srep00070 (2011). 1713 
41 Kane, A. E. et al. Impact of Longevity Interventions on a Validated Mouse Clinical Frailty 1714 
Index. J Gerontol A Biol Sci Med Sci 71, 333-339, doi:10.1093/gerona/glu315 (2016). 1715 
42 Kane, A. E. et al. A Comparison of Two Mouse Frailty Assessment Tools. J Gerontol A Biol Sci 1716 
Med Sci 72, 904-909, doi:10.1093/gerona/glx009 (2017). 1717 
43 Yu, D. et al. Short-term methionine deprivation improves metabolic health via sexually 1718 
dimorphic, mTORC1-independent mechanisms. FASEB J 32, 3471-3482, 1719 
doi:10.1096/fj.201701211R (2018). 1720 
44 Ramos, F. J. et al. Rapamycin reverses elevated mTORC1 signaling in lamin A/C-deficient 1721 
mice, rescues cardiac and skeletal muscle function, and extends survival. Sci Transl Med 4, 1722 
144ra103, doi:10.1126/scitranslmed.3003802 (2012). 1723 
45 Darcy, J. et al. Increased environmental temperature normalizes energy metabolism outputs 1724 
between normal and Ames dwarf mice. Aging (Albany NY), doi:10.18632/aging.101582 1725 
(2018). 1726 
46 Cohen, D. E., Supinski, A. M., Bonkowski, M. S., Donmez, G. & Guarente, L. P. Neuronal SIRT1 1727 
regulates endocrine and behavioral responses to calorie restriction. Genes Dev 23, 2812-1728 
2817, doi:10.1101/gad.1839209 (2009). 1729 
47 Dai, D. F. et al. Altered proteome turnover and remodeling by short-term caloric restriction 1730 
or rapamycin rejuvenate the aging heart. Aging Cell 13, 529-539, doi:10.1111/acel.12203 1731 
(2014). 1732 
48 Flynn, J. M. et al. Late-life rapamycin treatment reverses age-related heart dysfunction. 1733 
Aging Cell 12, 851-862, doi:10.1111/acel.12109 (2013). 1734 
49 Bitto, A. et al. Transient rapamycin treatment can increase lifespan and healthspan in 1735 
middle-aged mice. eLife 5, doi:10.7554/eLife.16351 (2016). 1736 
50 Chen, C., Liu, Y., Liu, Y. & Zheng, P. mTOR regulation and therapeutic rejuvenation of aging 1737 
hematopoietic stem cells. Sci Signal 2, ra75, doi:10.1126/scisignal.2000559 (2009). 1738 
51 Harrison, D. E. et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous 1739 
mice. Nature 460, 392-395, doi:10.1038/nature08221 (2009). 1740 
52 Hou, Y. et al. NAD(+) supplementation normalizes key Alzheimer's features and DNA damage 1741 
responses in a new AD mouse model with introduced DNA repair deficiency. Proc Natl Acad 1742 
Sci U S A 115, E1876-E1885, doi:10.1073/pnas.1718819115 (2018). 1743 
53 Spilman, P. et al. Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces 1744 
amyloid-beta levels in a mouse model of Alzheimer's disease. PLoS One 5, e9979, 1745 
doi:10.1371/journal.pone.0009979 (2010). 1746 
54 Baur, J. A. et al. Resveratrol improves health and survival of mice on a high-calorie diet. 1747 
Nature 444, 337-342, doi:10.1038/nature05354 (2006). 1748 
55 Fontana, L., Kennedy, B. K., Longo, V. D., Seals, D. & Melov, S. Medical research: treat ageing. 1749 
Nature 511, 405-407, doi:10.1038/511405a (2014). 1750 
56 Mitchell, S. J. et al. Daily Fasting Improves Health and Survival in Male Mice Independent of 1751 
Diet Composition and Calories. Cell Metab 29, 221-228 e223, 1752 
doi:10.1016/j.cmet.2018.08.011 (2019). 1753 
57 Wilkinson, J. E. et al. Rapamycin slows aging in mice. Aging Cell 11, 675-682, 1754 
doi:10.1111/j.1474-9726.2012.00832.x (2012). 1755 
58 Turturro, A. et al. Growth curves and survival characteristics of the animals used in the 1756 
Biomarkers of Aging Program. J Gerontol A Biol Sci Med Sci 54, B492-501 (1999). 1757 
59 Dumas, S. N. & Lamming, D. W. Next generation strategies for geroprotection via mTORC1 1758 
inhibition. J Gerontol A Biol Sci Med Sci, doi:10.1093/gerona/glz056 (2019). 1759 
60 Harrison, D. E. et al. Acarbose, 17-alpha-estradiol, and nordihydroguaiaretic acid extend 1760 
mouse lifespan preferentially in males. Aging Cell 13, 273-282, doi:10.1111/acel.12170 1761 
(2014). 1762 
61 Lamming, D. W. Diminished mTOR signaling: a common mode of action for endocrine 1763 
longevity factors. SpringerPlus 3, 735, doi:10.1186/2193-1801-3-735 (2014). 1764 
62 Strong, R. et al. Longer lifespan in male mice treated with a weakly estrogenic agonist, an 1765 
antioxidant, an alpha-glucosidase inhibitor or a Nrf2-inducer. Aging Cell 15, 872-884, 1766 
doi:10.1111/acel.12496 (2016). 1767 
63 Miller, R. A. et al. Rapamycin-mediated lifespan increase in mice is dose and sex dependent 1768 
and metabolically distinct from dietary restriction. Aging Cell 13, 468-477, 1769 
doi:10.1111/acel.12194 (2014). 1770 
64 Fontana, L. et al. Decreased Consumption of Branched-Chain Amino Acids Improves 1771 
Metabolic Health. Cell reports 16, 520-530, doi:10.1016/j.celrep.2016.05.092 (2016). 1772 
65 De Leon, E. R. et al. Age-Dependent Protection of Insulin Secretion in Diet Induced Obese 1773 
Mice. Scientific reports 8, 17814, doi:10.1038/s41598-018-36289-0 (2018). 1774 
66 Nadon, N. L., Strong, R., Miller, R. A. & Harrison, D. E. NIA Interventions Testing Program: 1775 
Investigating Putative Aging Intervention Agents in a Genetically Heterogeneous Mouse 1776 
Model. EBioMedicine 21, 3-4, doi:10.1016/j.ebiom.2016.11.038 (2017). 1777 
67 Yuan, R. et al. Genetic coregulation of age of female sexual maturation and lifespan through 1778 
circulating IGF1 among inbred mouse strains. Proc Natl Acad Sci U S A 109, 8224-8229, 1779 
doi:10.1073/pnas.1121113109 (2012). 1780 
68 Ryan, D. P. et al. A paternal methyl donor-rich diet altered cognitive and neural functions in 1781 
offspring mice. Molecular psychiatry 23, 1345-1355, doi:10.1038/mp.2017.53 (2018). 1782 
69 Fernandez-Twinn, D. S., Constancia, M. & Ozanne, S. E. Intergenerational epigenetic 1783 
inheritance in models of developmental programming of adult disease. Semin Cell Dev Biol 1784 
43, 85-95, doi:10.1016/j.semcdb.2015.06.006 (2015). 1785 
70 Martin-Gronert, M. S. & Ozanne, S. E. Early life programming of obesity. Med Wieku Rozwoj 1786 
17, 7-12 (2013). 1787 
71 Menting, M. D. et al. Maternal obesity in pregnancy impacts offspring cardiometabolic 1788 
health: Systematic review and meta-analysis of animal studies. Obes Rev, 1789 
doi:10.1111/obr.12817 (2019). 1790 
72 Dearden, L., Bouret, S. G. & Ozanne, S. E. Sex and gender differences in developmental 1791 
programming of metabolism. Molecular metabolism 15, 8-19, 1792 
doi:10.1016/j.molmet.2018.04.007 (2018). 1793 
73 Butterfield, N. N., Graf, P., Ries, C. R. & MacLeod, B. A. The effect of repeated isoflurane 1794 
anesthesia on spatial and psychomotor performance in young and aged mice. Anesth Analg 1795 
98, 1305-1311, (2004). 1796 
74 Xu, H. et al. Smaller sized inhaled anesthetics have more potency on senescence-accelerated 1797 
prone-8 mice compared with senescence-resistant-1 mice. Journal of Alzheimer's disease : 1798 
JAD 39, 29-34, doi:10.3233/JAD-130902 (2014). 1799 
75 Li, X. M. et al. Disruption of hippocampal neuregulin 1-ErbB4 signaling contributes to the 1800 
hippocampus-dependent cognitive impairment induced by isoflurane in aged mice. 1801 
Anesthesiology 121, 79-88, doi:10.1097/ALN.0000000000000191 (2014). 1802 
76 Li, R. L. et al. Postoperative impairment of cognitive function in old mice: a possible role for 1803 
neuroinflammation mediated by HMGB1, S100B, and RAGE. J Surg Res 185, 815-824, 1804 
doi:10.1016/j.jss.2013.06.043 (2013). 1805 
77 Campbell, J. E. & Drucker, D. J. Pharmacology, physiology, and mechanisms of incretin 1806 
hormone action. Cell Metab 17, 819-837, doi:10.1016/j.cmet.2013.04.008 (2013). 1807 
78 Linnemann, A. K. et al. Glucagon-Like Peptide-1 Regulates Cholecystokinin Production in 1808 
beta-Cells to Protect From Apoptosis. Mol Endocrinol 29, 978-987, doi:10.1210/me.2015-1809 
1030 (2015). 1810 
79 Renner, S., Blutke, A., Streckel, E., Wanke, R. & Wolf, E. Incretin actions and consequences of 1811 
incretin-based therapies: lessons from complementary animal models. J Pathol 238, 345-1812 
358, doi:10.1002/path.4655 (2016). 1813 
80 Leiter, E. H., Premdas, F., Harrison, D. E. & Lipson, L. G. Aging and glucose homeostasis in 1814 
C57BL/6J male mice. FASEB J 2, 2807-2811 (1988). 1815 
81 Ennaceur, A. & Delacour, J. A new one-trial test for neurobiological studies of memory in 1816 
rats. 1: Behavioral data. Behav Brain Res 31, 47-59 (1988). 1817 
82 Leger, M. et al. Object recognition test in mice. Nature protocols 8, 2531-2537, 1818 
doi:10.1038/nprot.2013.155 (2013). 1819 
83 Servick, K. Mouse microbes may make scientific studies harder to replicate. Science, 1820 
doi:10.1126/science.aah7199 (2016). 1821 
84 Cheng, C. J., Gelfond, J. A. L., Strong, R. & Nelson, J. F. Genetically heterogeneous mice 1822 
exhibit a female survival advantage that is age- and site-specific: Results from a large multi-1823 
site study. Aging Cell, e12905, doi:10.1111/acel.12905 (2019). 1824 
85 Kalueff, A. V., Keisala, T., Minasyan, A., Kuuslahti, M. & Tuohimaa, P. Temporal stability of 1825 
novelty exploration in mice exposed to different open field tests. Behav Processes 72, 104-1826 
112, doi:10.1016/j.beproc.2005.12.011 (2006). 1827 
86 Heyser, C. J. & Chemero, A. Novel object exploration in mice: not all objects are created 1828 
equal. Behav Processes 89, 232-238, doi:10.1016/j.beproc.2011.12.004 (2012). 1829 
87 Ennaceur, A. One-trial object recognition in rats and mice: methodological and theoretical 1830 
issues. Behav Brain Res 215, 244-254, doi:10.1016/j.bbr.2009.12.036 (2010). 1831 
88 Schnelle, M. et al. Echocardiographic evaluation of diastolic function in mouse models of 1832 
heart disease. J Mol Cell Cardiol 114, 20-28, doi:10.1016/j.yjmcc.2017.10.006 (2018). 1833 
89 Casaclang-Verzosa, G., Enriquez-Sarano, M., Villaraga, H. R. & Miller, J. D. Echocardiographic 1834 
Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart 1835 
Disease in Mice. Journal of visualized experiments : JoVE, doi:10.3791/54110 (2017). 1836 
90 Raber, J. Novel images and novel locations of familiar images as sensitive translational 1837 
cognitive tests in humans. Behav Brain Res 285, 53-59, doi:10.1016/j.bbr.2015.01.046 1838 
(2015). 1839 
91 Bettis, T. & Jacobs, L. F. Sex differences in object recognition are modulated by object 1840 
similarity. Behav Brain Res 233, 288-292, doi:10.1016/j.bbr.2012.04.028 (2012). 1841 
92 Prendergast, B. J., Onishi, K. G. & Zucker, I. Female mice liberated for inclusion in 1842 
neuroscience and biomedical research. Neurosci Biobehav Rev 40, 1-5, 1843 
doi:10.1016/j.neubiorev.2014.01.001 (2014). 1844 
93 Clayton, J. A. & Collins, F. S. Policy: NIH to balance sex in cell and animal studies. Nature 509, 1845 
282-283 (2014). 1846 
94 McCullough, L. D., McCarthy, M. M. & de Vries, G. J. NIH policy: status quo is also costly. 1847 
Nature 510, 340, doi:10.1038/510340b (2014). 1848 
95 Brooks, S. P., Pask, T., Jones, L. & Dunnett, S. B. Behavioural profiles of inbred mouse strains 1849 
used as transgenic backgrounds. II: cognitive tests. Genes Brain Behav 4, 307-317, 1850 
doi:10.1111/j.1601-183X.2004.00109.x (2005). 1851 
96 Frick, K. M. & Gresack, J. E. Sex differences in the behavioral response to spatial and object 1852 
novelty in adult C57BL/6 mice. Behav Neurosci 117, 1283-1291, doi:10.1037/0735-1853 
7044.117.6.1283 (2003). 1854 
97 Prut, L. & Belzung, C. The open field as a paradigm to measure the effects of drugs on 1855 
anxiety-like behaviors: a review. Eur J Pharmacol 463, 3-33 (2003). 1856 
98 Tschop, M. H. et al. A guide to analysis of mouse energy metabolism. Nature methods 9, 57-1857 
63, doi:10.1038/nmeth.1806 (2011). 1858 
99 Gregg, T. et al. Pancreatic beta-Cells From Mice Offset Age-Associated Mitochondrial 1859 
Deficiency With Reduced KATP Channel Activity. Diabetes 65, 2700-2710, doi:10.2337/db16-1860 
0432 (2016). 1861 
100 Klein, S. M. et al. Noninvasive in vivo assessment of muscle impairment in the mdx mouse 1862 
model--a comparison of two common wire hanging methods with two different results. J 1863 
Neurosci Methods 203, 292-297, doi:10.1016/j.jneumeth.2011.10.001 (2012). 1864 
101 Karp, N. A., Segonds-Pichon, A., Gerdin, A. K., Ramirez-Solis, R. & White, J. K. The fallacy of 1865 
ratio correction to address confounding factors. Lab Anim 46, 245-252, 1866 
doi:10.1258/la.2012.012003 (2012). 1867 
102 (U.S.), N. C. f. H. S. Health, United States, 2016 in With Chartbook on Long-term Trends in 1868 
Health.  (National Center for Heath Statistics, 2016). 1869 
103 Taffet, G. E., Pham, T. T. & Hartley, C. J. The age-associated alterations in late diastolic 1870 
function in mice are improved by caloric restriction. J Gerontol A Biol Sci Med Sci 52, B285-1871 
290 (1997). 1872 
104 Majumder, S. et al. Lifelong rapamycin administration ameliorates age-dependent cognitive 1873 
deficits by reducing IL-1beta and enhancing NMDA signaling. Aging Cell 11, 326-335, 1874 
doi:10.1111/j.1474-9726.2011.00791.x (2012). 1875 
105 Lin, A. L. et al. Chronic rapamycin restores brain vascular integrity and function through NO 1876 
synthase activation and improves memory in symptomatic mice modeling Alzheimer's 1877 
disease. J Cereb Blood Flow Metab 33, 1412-1421, doi:10.1038/jcbfm.2013.82 (2013). 1878 
106 Ozcelik, S. et al. Rapamycin attenuates the progression of tau pathology in P301S tau 1879 
transgenic mice. PLoS One 8, e62459, doi:10.1371/journal.pone.0062459 (2013). 1880 
107 Caccamo, A., Majumder, S., Richardson, A., Strong, R. & Oddo, S. Molecular interplay 1881 
between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on 1882 
cognitive impairments. J Biol Chem 285, 13107-13120, doi:10.1074/jbc.M110.100420 (2010). 1883 
108 Cummings, N. E. & Lamming, D. W. Regulation of metabolic health and aging by nutrient-1884 
sensitive signaling pathways. Molecular and cellular endocrinology 455, 13-22, 1885 
doi:10.1016/j.mce.2016.11.014 (2017). 1886 
109 Lamming, D. W. & Anderson, R. M. Metabolic Effects of Caloric Restriction in eLS.  (John 1887 
Wiley & Sons, Ltd, 2014). 1888 
110 Malloy, V. L. et al. Methionine restriction decreases visceral fat mass and preserves insulin 1889 
action in aging male Fischer 344 rats independent of energy restriction. Aging Cell 5, 305-1890 
314, doi:10.1111/j.1474-9726.2006.00220.x (2006). 1891 
111 Green, C. L. & Lamming, D. W. Regulation of metabolic health by essential dietary amino 1892 
acids. Mech Ageing Dev, doi:10.1016/j.mad.2018.07.004 (2018). 1893 
112 Fang, Y. et al. Duration of rapamycin treatment has differential effects on metabolism in 1894 
mice. Cell Metab 17, 456-462, doi:10.1016/j.cmet.2013.02.008 (2013). 1895 
113 Brewer, R. A., Gibbs, V. K. & Smith, D. L., Jr. Targeting glucose metabolism for healthy aging. 1896 
Nutr Healthy Aging 4, 31-46, doi:10.3233/NHA-160007 (2016). 1897 
114 Lusk, G. ANIMAL CALORIMETRY: Twenty-Fourth Paper. ANALYSIS OF THE OXIDATION OF 1898 
MIXTURES OF CARBOHYDRATE AND FAT. Journal of Biological Chemistry 59, 41-42 (1924). 1899 
115 Goodpaster, B. H. & Sparks, L. M. Metabolic Flexibility in Health and Disease. Cell Metab 25, 1900 
1027-1036, doi:10.1016/j.cmet.2017.04.015 (2017). 1901 
116 Solon-Biet, S. M. et al. Dietary Protein to Carbohydrate Ratio and Caloric Restriction: 1902 
Comparing Metabolic Outcomes in Mice. Cell reports 11, 1529-1534, 1903 
doi:10.1016/j.celrep.2015.05.007 (2015). 1904 
117 Lee, A. S. et al. Aged skeletal muscle retains the ability to fully regenerate functional 1905 
architecture. Bioarchitecture 3, 25-37, doi:10.4161/bioa.24966 (2013). 1906 
118 van Norren, K. et al. Behavioural changes are a major contributing factor in the reduction of 1907 
sarcopenia in caloric-restricted ageing mice. J Cachexia Sarcopenia Muscle 6, 253-268, 1908 
doi:10.1002/jcsm.12024 (2015). 1909 
119 Ge, X. et al. Grip strength is potentially an early indicator of age-related decline in mice. 1910 
Pathobiol Aging Age Relat Dis 6, 32981, doi:10.3402/pba.v6.32981 (2016). 1911 
120 Hirsch, C. H., Buzkova, P., Robbins, J. A., Patel, K. V. & Newman, A. B. Predicting late-life 1912 
disability and death by the rate of decline in physical performance measures. Age Ageing 41, 1913 
155-161, doi:10.1093/ageing/afr151 (2012). 1914 
121 Bogue, M. A. et al. Accessing Data Resources in the Mouse Phenome Database for Genetic 1915 
Analysis of Murine Life Span and Health Span. J Gerontol A Biol Sci Med Sci 71, 170-177, 1916 
doi:10.1093/gerona/glu223 (2016). 1917 
122 Xu, M. et al. JAK inhibition alleviates the cellular senescence-associated secretory phenotype 1918 
and frailty in old age. Proc Natl Acad Sci U S A 112, E6301-6310, 1919 
doi:10.1073/pnas.1515386112 (2015). 1920 
123 Peterson, R. L., Parkinson, K. C. & Mason, J. B. Manipulation of Ovarian Function Significantly 1921 
Influenced Sarcopenia in Postreproductive-Age Mice. J Transplant 2016, 4570842, 1922 
doi:10.1155/2016/4570842 (2016). 1923 
124 Graber, T. G., Ferguson-Stegall, L., Kim, J. H. & Thompson, L. V. C57BL/6 neuromuscular 1924 
healthspan scoring system. J Gerontol A Biol Sci Med Sci 68, 1326-1336, 1925 
doi:10.1093/gerona/glt032 (2013). 1926 
125 Simmons, D. A. et al. A small molecule TrkB ligand reduces motor impairment and 1927 
neuropathology in R6/2 and BACHD mouse models of Huntington's disease. J Neurosci 33, 1928 
18712-18727, doi:10.1523/JNEUROSCI.1310-13.2013 (2013). 1929 
126 Jeong, H. et al. Sirt1 mediates neuroprotection from mutant huntingtin by activation of the 1930 
TORC1 and CREB transcriptional pathway. Nat Med 18, 159-165, doi:10.1038/nm.2559 1931 
(2011). 1932 
127 Zhang, Y. et al. Rapamycin extends life and health in C57BL/6 mice. J Gerontol A Biol Sci Med 1933 
Sci 69, 119-130, doi:10.1093/gerona/glt056 (2014). 1934 
 1935 
Data availability 1936 
All data shown in this paper are available from the authors upon reasonable request. 1937 
 1938 
Acknowledgments 1939 
This article is based upon work from COST Action (BM1402: MouseAGE), supported by 1940 
COST (European Cooperation in Science and Technology). Part of this work has been 1941 
funded by the European Union Research and Innovation Program Horizon 2020 (Grant 1942 
Agreement Number 730879). The Lamming laboratory is supported in part by the NIH 1943 
(AG051974, AG056771, and AG062328) and by the U.S. Department of Veterans Affairs 1944 
(I01-BX004031), and this work was supported using facilities and resources from the William 1945 
S. Middleton Memorial Veterans Hospital. RdC, CDG and IN are supported by the Intramural 1946 
Research Program of the NIA/NIH. This work does not necessarily represent the official 1947 
views of the NIH, the Department of Veterans Affairs or the United States Government. 1948 
 1949 
Author contributions 1950 
Ilaria Bellantuono, Rafael de Cabo, Dan Ehninger, Clara Di Germanio, Ignacio Navas-1951 
Enamorado, Sarah Mitchell, Paul Potter, Tamar Tchkonia, Jose Luis Trejo and Dudley 1952 
Lamming contributed equally to the development of the protocols. Ilaria Bellantuono and 1953 
Dudley Lamming wrote the manuscript and all the other authors edited and approved.  1954 
 1955 
Competing interests 1956 
The authors declare no competing financial interests. 1957 
 1958 
  1959 
Figure legends 1960 
 1961 
Figure 1. A graphic representation of the experimental design for healthspan assessment in 1962 
response to a geroprotector of choice in C57BL6/J using the recommended toolbox. At each 1963 
time point the multiple tests are performed over a period of 4-6 weeks, leaving those which 1964 
may impact more on the animal at the end. In this case we recommend the following order, 1965 
novel object recognition, frailty index, grip strength, cage top and hanging bar followed by 1966 
rotarod, body composition, energy expenditure, glucose tolerance test (GTT), Insulin 1967 
tolerance test (ITT) and echocardiography. Mo, Month 1968 
Figure 2. Representative images from high resolution echocardiography systems. A) 1969 
Representative image of M-mode image used for assessment of cardiac systolic function 1970 
(AW = anterior wall, PW = posterior wall, LVEDD = left ventricular diastolic dimensions, 1971 
LVESD = left ventricular systolic dimensions; arrows denote the thickness/dimension of 1972 
interest for each variable). B) Representative image of pulsed-wave Doppler assessment of 1973 
peak mitral valve inflow (E) using color Doppler guidance (IVRT = isovolumic relaxation time, 1974 
IVCT = isovolumic contraction time, LVET = left ventricular ejection time). C) Representative 1975 
image of tissue Doppler assessment of the septal mitral annulus velocity (e’) using the 1976 
spectral velocity display.  White arrows denote the point of measurement.  Images are 1977 
reproduced from Verzosa and colleagues89 with permission. Animal procedures were 1978 
performed following approval by the Mayo Clinic Institutional Animal Care and Use 1979 
Committee.  1980 
 1981 
Figure 3. NOR memory enhancement in exercised fathers and their offspring. (A–B) 1982 
NOR memory enhancement in exercised (RUN) vs. sedentary (SED) animals. 1983 
Results represent as Discrimination index (DI). A DI score of >0.20 was set ad hoc to 1984 
determine proper novel-object discrimination; statistically significant within-group differences 1985 
were also considered between the training phase and the test phases. (A) Before exercising, 1986 
mice were unable to discriminate the novel object in a difficult protocol. B) After 6 wk of 1987 
physical exercise, exercised animals showed memory enhancement. For comparisons 1988 
between independent groups, *P < 0.05; for intragroup differences (LTM vs training), +P < 1989 
0.05; tendencies 0.05 > #P < 0.09. Extreme values were removed from the analysis. SED A, 1990 
n = 4; RUN A, n = 5. Figure adapted with permission from McGreevy et al, 2019, PNAS 33. 1991 
The animal procedures were performed following approval by the Committee of Ethics and 1992 
Animal Experimentation of the Cajal Institute, Ethics Committee of the CSIC, and the Animal 1993 
Protection Area of the Ministry of Environment of the Community of Madrid. LTM, Long term 1994 
memory, STM short term memory 1995 
 1996 
Figure 4. Effects of dietary protein level on energy balance. Metabolic chambers were 1997 
used to assess A) Food Consumption, B) Spontaneous activity (as assessed by wheel 1998 
running), C-E) Respiration and F) Energy Expenditure over a 24-hour period after 1999 
approximately 8 weeks on the indicated diets (n=8-9/group, two-tailed t-test, * = p < 0.05). 2000 
Error bars represent standard error. Figure is adapted from 64 with permission. Animal 2001 
procedures were performed following approval by the Institutional Animal Care and Use 2002 
Committee of the William S. Middleton Memorial Veterans Hospital. 2003 
 2004 
Figure 5. Glucose and insulin tolerance tests. A) Glucose tolerance test conducted on 2005 
male C57BL/6J mice treated with either vehicle or with 2 mg/kg rapamycin (1x/day or 1x/5 2006 
days) for 2 weeks (n = 9 per treatment; for GTT, Tukey–Kramer test following two-way 2007 
repeated measures ANOVA, a = P < 0.05 vehicle vs rapamycin 1x/day, b = P < 0.05 vehicle 2008 
vs. rapamycin 1x/5 days; for AUC, means with the same letter are not significantly different 2009 
from each other, Tukey–Kramer test following one-way ANOVA, P < 0.05). Figure is adapted 2010 
from 16 with permission. B) Insulin tolerance test on female C57BL/6J.Nia mice treated with 2011 
either vehicle or rapamycin (2 mg/kg) once every 5 days for 8 weeks (n = 7–10 vehicle, n = 2012 
10 rapamycin, two-tailed t-test). Test was performed 5 days after the last administration of 2013 
either vehicle or rapamycin, at the conclusion of an overnight fast. Figure is adapted from 2014 
6with permission. Error bars represent standard error. Animal procedures were performed 2015 
following approval by the Institutional Animal Care and Use Committee of the William S. 2016 
Middleton Memorial Veterans Hospital. 2017 
 2018 
Figure 6. Assessment of muscle strength and neuromuscular function. Physical 2019 
function measurements in 20-month-old male mice treated with dasatinib and Quercetin 2020 
(D+Q) once every 2 weeks (bi-weekly) for 4 months. (a) Grip strength,  (b) hanging 2021 
endurance,  and (c) maximal walking speed on rotarod (relative to baseline) 4 months after 2022 
drug initiation (n = 20 for D+Q; n = 13 for V). Results are shown as box and whiskers plots, 2023 
where a box extends from the 25th to 75th percentile with the median shown as a line in the 2024 
middle, and whiskers indicate smallest and largest values. *P <0.05; n.s., not significant; 2025 
Two-tailed Student’s t-tests. Figure is adapted from 29with permission. Animal procedures 2026 
were performed following approval by the Mayo Clinic Institutional Animal Care and Use 2027 
Committee. 2028 
 2029 
  2030 
Table 1 2031 
Estimated timing for each test for n=10 animals and n=2 operators.  2032 
 2033 
 2034 
Week # Test  Comments 
1 NOVEL OBJECT RECOGNITION 
 
• Day 1. Habituation: 30 min/mouse 
• Day 2. Training phase: 5-15 min/mouse 
                     Test phase: For STM, after 1 hour of 
training                                                                         
phase. 10 min/mouse. 
• Day 3. Test phase: For LTM, after 24h of 
training phase. 10min/mouse. 
 
For Day 1, estimated time is 5-
6 hours. 
For Day 2, estimated time is 
between 3:30h and 5:15h with 
STM same day or 2:00h - 3h 
without STM. 
For Day 3, estimated time is 2h. 
2 MUSCLE STRENGTH AND NEUROMUSCULAR 
FUNCTION 
 
• Day 1. Grid Hanging. 3 trials per animal 
allowing 30 min in between trials. * 
• Day 2. Grip Strength. 3 trials per animal 
allowing 30 min in between trials. Time 
estimate is 3 min per animal. 
• Day 2. Frailty index. 15min/animal 
• Day 3. REST Day 
• Day 4. Hanging Bar. 3 trials per animal 
allowing 30 min in between trials. *** 
• Day 5. Rotarod. 3 trials per animal allowing 30 
min in between trials. Time estimate is 3 min 
per animal.  
 
*depending the age/sex of the 
animals, estimated total time 
might vary between 1h and 4h. 
** This will take 2-3h  
*** depending the age/sex of 
the animals, estimated total 
time might vary between 1h 
and 3h. 
SIDE NOTE: in some tests, 
total time estimated will depend 
of the number of different set-
ups available. Some apparatus 
allow the operator to run 
multiple animals at a time like 
multi-channel rotarod or grid 
hanging test. However the 
operator must be continually 
scanning and monitoring all 
animals during this time.  
3 BODY COMPOSITION and ENERGY BALANCE 
 
• Day 1. Body Composition Test. Experiment 
takes 2 min/mouse. Estimated time is 1h. 
• Day 2. Energy balance test. Prepare the 
animals, calibrating and setting up the 
experiment and run the experiment. Estimated 
time 2h. 
• Day 3. Energy balance test. The software is 
up and running recording in vivo metabolic 
data. * 
• Day 4. Energy balance test. The software is 
up and running recording in vivo metabolic 
data. * 
• Day 5. Energy balance test. Stop the 
experiment, exporting the data, cleaning the 
equipment and putting animals back in home 
*schedule based on a 72h 
experiment set-up with two light 
cycles and two dark cycles of 
12h/each. 
Side note: During these 
recording days, animals have to 
be checked by the operator to 
make sure they are in good 
condition and have access to 
food and water. Also software 
needs to be checked in order to 
make sure data is being 
collected accurately. 
Two people can expedite the 
set up of these tests. One 
person does the body 
composition measurement, the 
cages and room. Estimated time 2h.  other sets up the in vivo 
metabolic machine for 
calibration and measurement. 
4 GLUCOSE TOLERANCE TEST 
 
• Day 0. Fast animals 6 or 16 hours before the 
start of the test 
• Day 1. Test day. The last of the time points is 
at 2 hours after the beginning of the test. To 
allow for setup and clean up, an additional 1.5-
2h is needed. Therefore, total time required is 
3.5-4h.  
Due to the invasive and 
stressful character of the test, 
we let the animals rest the 
whole week after the test. 
A skilled person can inject 
between 20-30 mice within 
15min. After the conclusion of 
the test, animals are returned to 
their home cage. Mice should 
be checked after 4-6h to ensure 
they have returned to normal. 
5 INSULIN TOLERANCE TEST 
 
• Day 1. Fast animals. Animals need to be fasted 
3-6h before the experiment.* 
 
Test. The last of the time points is at 2 
hours after the beginning of the test. To allow 
for setup and clean up, an additional 1.5-2h is 
needed. Therefore total time required is 3.5-4h. 
 
*Fasting periods might vary 
between different studies. We 
propose for longitudinal studies 
a fasting between 3h and 6h. 
Due to the invasive and 
stressful nature of this test, we 
let the animals rest the whole 
week after the test. 
A skilled person can inject 
between 20-30 mice within 
15min.  
After the conclusion of the test, 
animals are returned to their 
home cage. Mice should be 
checked after 4-6h to ensure 
they have returned to normal. 
6 CARDIAC FUNCTION 
 
Day 1. Echocardiogram. Mice are anesthetized using 
isoflurane-oxygen Echocardiograms can take up to 30-
45min per animal depending on the age, strain and 
bodyweight. Obese mice can be harder to image given 
their excess amounts of fat.  
 
Day 2. Data processing. 1h 
Caution must be taken for old 
mice who are more vulnerable 
to death from isoflurane.  
A skilled operator can process 
up to 10 animals per day. 
Mice should be given at least 5 
days (longer for aged mice) to 
recover from the isoflurane.   
 2035 
